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“It is unreasonable to expect that people will change their behavior easily when so many 
forces in the social, cultural, and physical environment conspire against such change. If 
successful programs are to be developed to prevent disease and improve health, attention 
must be given not only to the behavior of individuals, but also to the environmental 
context within which people live” (Institute of Medicine, 2000)1.  
                                               
1  Smedley BD and Syme LS. Promoting Health. Intervention Strategies from Social and Behavioral 
Research. Washington: Institute of Medicine; 2000: 5  
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Zusammenfassung (deutsche Version) 
 
Der größer werdende Anteil mikrovaskulärer Diabeteskomplikationen ist ein 
zunehmendes Problem in der mexikanischen Bevölkerung. Dabei sind Menschen in 
einkommensschwachen- und strukturell benachteiligten Regionen einem höheren Risiko 
ausgesetzt, früher an Diabeteskomplikationen zu erkranken. Um die Rate neu 
aufgetretener Diabeteskomplikationen effektiv zu reduzieren, ist eine frühzeitige 
Diagnosestellung und medizinische Betreuung notwendig. Jedoch konnte eine 
umfassende Diabetesversorgung in einkommensschwachen und abgelegenen Regionen 
Mexiko’s bisher nicht umgesetzt werden.  
 
Das Ziel dieser Studie ist, herauszufinden, inwiefern soziale- und geopolitische Faktoren 
die Inanspruchnahme präventiver Maßnahmen und damit die Entwicklung diabetischer 
Komplikationen beeinflussen.   
Zu diesem Zwecke werden im Folgenden die Punkte i-iii untersucht: 
i) Sozioökonomische Unterschiede zwischen Diabetikern mit und ohne 
Diabeteskomplikationen. 
ii) Einflussfaktoren auf das Vorhandensein von Diabeteskomplikationen auf regionaler- 
und Bundeslandebene.  
iii) Einfluss ländlicher Herkunft auf die Inanspruchnahme präventiver Maßnahmen und 
das Vorhandensein von Diabeteskomplikationen.   
 
Dafür benutzten wir Querschnittsdaten der mexikanischen Gesundheits- und 
Ernährungsumfrage (ENSANUT) 2012. Mittels einer systematischen Literaturrecherche 
wurde die Verfügbarkeit epidemiologischer Studien in Bezug auf mikrovaskuläre 
Diabeteskomplikationen untersucht und die Ergebnisse der ENSANUT 2012 mit 
Ergebnissen vorhergehender Studien aus Mexiko verglichen.  
Für die weitere Datenanalyse wurden 4,261 befragte Studienteilnehmer im Alter von 20 
Jahren und älter mit bekannter Diabetesdiagnose eingeschlossen. Univariate Analyse, 
Datenvisualisierung und multiple logistische Regressionsmodelle kamen zur Anwendung 
um Zusammenhänge zwischen sozioökonomischer Determinanten, Inanspruchnahme von  
Präventivmaßnahmen und Vorhandensein von Diabeteskomplikationen im ländlichen-
und städtischen Raum, sowie zwischen den 32 Staaten Mexiko’s zu untersuchen.  
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Aus den Ergebnissen geht hervor, dass selbst-berichtete Daten in Bezug auf die Prävalenz 
mikrovaskulärer Diabeteskomplikationen von 44.7% bis zu 77.1% variieren. Höchste 
Prävalenzen traten gruppiert im Zentrum der West und Ostküste und entlang des Golfs 
von Mexiko auf. Sozioökonomische Faktoren (niedriger soziökonomischer Status und 
Bildungsstandard, Marginalisierung und fehlende Krankenversicherung) waren positiv 
mit dem Auftreten von Diabeteskomplikationen assoziiert. Jedoch konnte bei der 
visuellen Inspektion der Prävalenzdaten, kein Zusammenhang zwischen geographischer 
Häufung von Diabeteskomplikationen und sozioökonomischer Entwicklung der 
zugehörigen Region gefunden werden.  
Die weitere Analyse ergab, dass ländlicher Wohnsitz signifikant mit dem Auftreten von 
Diabeteskomplikationen assoziiert war (OR = 1.31; 95%CI = 1.02 – 1.69). Ebenso gaben 
71% der befragten Studienteilnehmer aus ländlichen Regionen an, in den letzten 12 
Monaten an keiner Diabetesvorsorge teilgenommen zu haben, im Vergleich zu 60% der 
Studienteilnehmer aus urbanen Regionen (p < 0.001). 
 
Daraus ergibt sich, dass weitere Interventionen auf gesundheitspolitischer Ebene 
notwendig sind, um die Inanspruchnahme und Compliance von Präventivmaßnahmen 
unter Diabetikern zu fördern und damit die Krankheitslast im ländlichen Mexiko zu 
senken. Es besteht weiterhin Unklarheit, ob eine kausale Beziehung zwischen 
sozioökonomischem Status und geographischer Gruppierung von 
Diabeteskomplikationen zwischen Mexiko’s Staaten besteht. 
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Summary 
 
The increasing number of people with microvascular diabetes complications is an 
emerging problem in Mexico. People with less financial resources and those living in 
deprived areas in terms of infrastructure are at an elevated risk of developing diabetes 
complications earlier in their lifetime. Early detection and care of diabetes is necessary in 
order to effectively control and reduce the rate of complications. However, providing 
comprehensive diabetes care in low-income settings and remote areas of Mexico has not 
yet been achieved (Tapia-Conyer, Gallardo-Rincón, & Saucedo-Martinez, 2013).   
 
The aim of this study is to determine how social and geopolitical determinants influence 
the utilisation of preventive measures and with that the development of diabetes 
complications. In order to do this, we explore the following points: 
i) Socioeconomic differences between people with and without diabetes complications. 
ii) The impact of the area of residency in Mexico’s socio-economical diverse regions on 
the prevalence of microvascular diabetes complications  
iii) How rural residency affects utilisation of preventive measures and the presence of 
diabetes complications 
 
We used cross-sectional data from the Mexican Health and Nutrition Survey 
(ENSANUT) 2012. A systematic literature review was conducted to assess the 
availability of epidemiological studies on microvascular diabetes complications and 
compare self-reported data from the ENSANUT 2012 with evidence from prior research 
conducted in Mexico.  
For further data analysis, 4,261 respondents aged 20 years and older with diabetes were 
included in the study. Univariate analysis, data visualization and multiple logistic 
regression models were performed to test associations between social determinants, the 
utilisation of preventive measures and the presence of diabetes complications in rural and 
urban areas as well as between Mexico’s 32 federal states.  
 
The results demonstrate that self-reported presence of microvascular diabetes 
complications varies from 44.7% to 77.1%. The highest prevalence is clustered in the 
centre of the West and the East coast and along the Gulf of Mexico. Socioeconomic 
factors (lower socioeconomic and educational status, marginalisation and absence of 
health insurance) are positively associated with the presence of diabetes complications. 
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However, upon visual inspection, the geographical clustering of diabetes complications 
was not associated with the socioeconomic development of the area.  
Further analysis revealed that rural residency is significantly associated with the presence 
of diabetes complications (OR = 1.31; 95%CI = 1.02 – 1.69), and 71% of rural residents 
had not performed any preventive measure in the past 12 months compared to 60% in 
urban areas (p < 0.001). 
 
Based on these results, health political efforts to improve the feasibility and compliance 
of preventive diabetes care in rural areas should be undertaken to decrease the burden of 
disease. If a causal relationship between socioeconomic status and the geographical 
clustering of diabetes complications across Mexico’s states exists, needs to be further 
evaluated.  
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1 PART I: Epidemiology of diabetes complications in Mexico and Central 
America – A systematic literature review 
1.1 Introduction 
1.1.1 Diabetes in low- and middle-income countries 
Diabetes is known to be an emerging problem all over the globe. Approximately 8.3% of 
the world population suffers from diabetes(Kwak & Park, 2015). With regard to Latin 
America, it is estimated that around 26 million people and 9 million people in Mexico 
suffer from diabetes (International Diabetes Federation, 2013).  
The prevalence of type 2 diabetes mellitus (T2DM) is steadily increasing, with a great 
increase observed in low- and middle-income countries (LMIC). Specifically, it was 
predicted that between 1995 and 2025 the number of individuals with diabetes would 
increase by 170% in LMICs compared to a 42% increase in nations with high 
income(Esterson, Carey, Piette, Thomas, & Hawkins, 2014). At present, approximately 
80% of the people with diabetes live in LMICs, which are more affected by the 
consequences of T2DM compared to high-income nations (Seuring, Archangelidi, & 
Suhrcke, 2015).  
The Central American region is located between the isthmus of Tehuantepec (at the 
Guatemalan-Mexican border) and Panama. Mexico does not strictly belong to the Central 
American region, but it shares a great part of its cultural and historical heritage. As for 
the whole Latin American region, diabetes is an emerging problem, which requires more 
health care facilities and health care workers to serve the ever-increasing demand for 
diabetes care. However, four of the eight countries in Central America and Mexico have 
fewer than 23 health care workers per 10.000 people, which is the number of workers 
necessary to cover the primary health care needs of a population according to the World 
Health Organization (World Health Organization, 2009). Greater disparities in health care 
supply exist between rural and urban regions, with shortages of rural physicians and 
specialists in the Latin American region (Centers for Disease Control and Prevention, 
2017; Colon-Gonzalez, El Rayess, Guevara, & Anandarajah, 2015). With regard to 
diabetes, less access to health care, misperceptions of the concept of chronic diseases and 
the high costs of medication compared to wages have made adherence to treatment 
increasingly difficult in the past. The consequences have included the late detection of 
diabetes, insufficient controlled risk factors and lack of prevention that resulted in 
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micro/macrovascular complications with stronger impacts on poor and disadvantaged 
population groups. Diabetes complications disable people at economically productive 
ages, and an increase in early onset diabetes (before the age of 40) has been observed in 
recent years, which has increased the demand for and necessity of fostering awareness for 
the prevention of diabetes complications (Wilmot & Idris, 2014).  
1.1.2 Why diabetes complications are a major problem in Central America 
and Mexico 
Some of the reasons for the accelerated increase in diabetes over the past decades include 
epidemiological transition, globalisation and urbanisation, which has led to changing 
dietary patterns and a shift from manual labour to sedentary lifestyles(Islam et al., 2015). 
The epidemiological transition is based on the theory that profiles of countries change in 
accordance to their state of development. This change is reflected in higher life 
expectancies, decreased fertility rates and changing patterns in disease risk and mortality, 
with higher counts of chronic and non-communicable diseases and lower proportions of 
communicable and infectious diseases(McKeown, 2009). More developed countries in 
Latin America (e.g. Uruguay) have completed epidemiological transitions and are 
characterised by a high number of non-communicable diseases and lower mortality rates 
due to infectious diseases. Mexico and Costa Rica are at late stages of the 
epidemiological transition and experienced the highest increase in non-communicable 
diseases between 1980 and 1990(Stevens et al., 2008). Developing countries in Central 
America, particularly Guatemala, Honduras, Nicaragua and El Salvador, are facing a 
delayed transition with high numbers of deaths due to communicable diseases, 
undernutrition, maternal and perinatal causes and increasing rates of non-communicable 
diseases(Marinho, Soliz, Gawryszewski, & Gerger, 2013). Similar observations have 
been made across different areas in Mexico(Stevens et al., 2008). Countries and areas at 
earlier stages of the transition could face a double burden with high numbers of 
communicable and non-communicable diseases. With regard to diabetes, the 
epidemiological transition produces increased numbers of people that develop diabetes 
complications, especially in pre-transitional areas where the focus remains on treatment 
of communicable diseases rather than on the prevention of the development and 
progression of chronic conditions. Furthermore, the disability caused by diabetes 
complications and other non-communicable diseases can lead to a decrease in working 
hours, increased risk of hospitalisations and health expenditures that exceed the financial 
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capacities of poor populations, resulting in a circle of impoverishment due to illness 
(Daivadanam, 2012). 
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1.1.3 Problem outline – Availability of epidemiological data on diabetes  
Estimating the prevalence of diabetes complications is essential in order to evaluate the 
impact and future burden of diabetes. However, accurate estimations of the prevalence of 
diabetes and diabetes complications are difficult to assess due to large numbers of 
undiagnosed people, diagnostic differences and inconsistent registration and 
documentation of diabetes complications. Approximately 24% to 50% of the adult 
population in the South and Central American region are undiagnosed(Aschner et al., 
2014). Increased numbers of undiagnosed cases are mainly a result of lack of knowledge 
and education, barriers to health care and insufficient data management among different 
health care providers. People living in rural and remote areas, ethnic minorities and 
people with low financial capacities are especially at risk of remaining undiagnosed and 
developing diabetes complications at earlier ages. The International Diabetes Federation 
(IDF) regularly publishes estimations on the prevalence and burden of diabetes across the 
adult population for most countries in the world. Despite its reputation of producing 
reliable and high-quality information, the publications for some countries lack sufficient 
data for one to make correct estimations. For example, the information on Panama and El 
Salvador is based on extrapolation using countries with similar demographic and 
geographic characteristics(Aschner et al., 2014) and epidemiological diabetes 
surveillance has not been applied in most Latin American countries (Barcelo & 
Rajpathak, 2001).  
In the following section, we provide a brief description of clinical symptoms, diagnostic 
measures, therapy and preventive measures of the most common microvascular diabetes 
complications. The first section of this analysis comprises systematic literature research 
with the intention of clarifying the availability of epidemiological data of diabetes 
complications in Central America and Mexico. We further discuss the results and 
critically review methodological approaches to make estimations about diabetes 
complications.  
The second section provides a detailed analysis of microvascular diabetes complications 
in Mexico with the intention of exploring demographic, socioeconomic and health access 
factors that contribute to the presence of diabetes complications and consequently impact 
the distribution of diabetes complications across Mexican states and across rural/urban 
areas of Mexico. The third and last section further analyses rural and urban people with 
diabetes complications and their participation in preventive screenings in Mexico.  
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1.1.4 Diabetes complications – Aetiology, diagnosis, treatment and 
prevention 
Diabetic vascular complications have reasonable impacts on quality of life given that they 
are a major cause of various disabilities like acquired blindness, End Stage Renal Disease 
(ESRD), Lower Extremity Amputations (LEA), diabetic neuropathy (DN) and 
cardiovascular disease, which account for higher mortality rates in patients with diabetes. 
Although a greater focus in literature lies on macrovascular complications, due to the 
increased epidemiological importance of cardiovascular diseases in recent years, 
microvascular complications are highly disabling conditions. Additionally, microvascular 
complications have been demonstrated as targetable by prevention and are therefore 
indicators of the quality and quantity of diabetes care(Sharma, Sharma, Maheshwari, 
Sharma, & Gupta). However, the development of diabetes complications also depends on 
environmental factors and genetic dispositions, including familial aggregation and racial 
differences, which are not modifiable(Kwak & Park, 2015). Environmental factors 
including duration of diabetes, degree of hyperglycaemia, blood pressure and 
dyslipidaemia are modifiable risk factors, and effective control decreases the morbidity 
and mortality of patients with diabetes. International guidelines define the type and 
amount of preventive screenings (HbA1c tests, foot and eye revision, renal impairment 
testing, etc.) necessary to achieve adequate blood glucose control and reduce risk factors. 
According to international and Mexican guidelines, preventive screenings should be 
assessed at least annually, and other comorbidities such as hyperlipidaemia and arterial 
hypertension should be treated and controlled regularly(Secretaria de Salud, 2010) 
(American Diabetes Association, 2012).  
 
Diabetic vascular complications are divided into two main groups:  
1) Microvascular complications  
2) Macrovascular complications 
Microvascular complications affect the capillary bed of organs, mainly causing diabetic 
retinopathy, nephropathy, neuropathy, diabetic foot ulcers (DF) and lower extremity 
amputations. Macrovascular complications are associated with cardiovascular diseases 
like the manifestations of coronary heart disease, strokes and peripheral vascular diseases. 
In the following section, microvascular diabetes complications that are included in this 
analysis are further described. 
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1.1.4.1 Diabetic neuropathy, diabetic foot ulcers and lower extremity 
amputations 
The most common form of DN (‘chronic sensorimotor distal symmetric polyneuropathy 
(DPN)’) was estimated to be present in about 20% to 50% of adult diabetic patients living 
in the US in 2005 (Boulton et al., 2005). Diabetic neuropathy is characterised by a 
progressive loss of distal sensation, leading in some cases to motor weakness through 
axonal loss(Feldmann, Shefner, & Dashe, 2015). Other forms of DN include diabetic 
autonomic neuropathy and focal neuropathy, with gastroparesis, constipation, diarrhea, 
anhidrosis, bladder dysfunction, erectile dysfunction, exercise intolerance, resting 
tachycardia, silent ischemia and sudden cardiac death(Edwards, Vincent, Cheng, & 
Feldman, 2008).  
Patients with DPN report numbness, burning or ‘electrical’ pain, which gets worse at 
night, and loss of the sensation of light touch, vibration and temperature during physical 
examination(Fowler, 2008). Distal symmetric polyneuropathy increases the risk of 
developing painless foot ulcers that can remain undetected(Millan-Guerrero et al., 2012). 
This, in turn, predestines for ulcer infections and increased risk of LEA. People with 
diabetes experience LEA 17 to 40 times more often compared to people without diabetes, 
and about 85% of all people with LEA have had a previous foot ulcer(Boulton, 2004; 
Fard, Esmaelzadeh, & Larijani, 2007). Subsequent amputations are common. About 50% 
of people with one LEA undergo another LEA within five years (Monteiro-Soares, 
Boyko, Ribeiro, Ribeiro, & Dinis-Ribeiro, 2011). Furthermore, the mortality rate after 
LEA increases to 70% in the fifth year after amputation(Larsson, D Agardh, Apelqvist, & 
Stenström, 1998).  
According to guidelines from the American Diabetes Association (ADA), a physician 
should perform a comprehensive foot exam at the onset of diabetes and at least once 
annually afterwards. This foot exam should include an assessment of risk factors, history 
of previous foot ulcers, a vascular and dermatological assessment with a focus on skin 
lesions and musculoskeletal deformities. Furthermore, any of the five neurological exams 
are recommended to detect DPN or any progression. These include the use of a 10-gram 
monofilament, a pinprick sensation test, a vibration test using a 128-Hz tuning fork or 
biothesiometer and/or ankle reflex assessment (American Diabetes Association, 2015).   
Apart from tight glycemic control, which demonstrated modest effects on progression, no 
specific treatment for DN is available. However, blood glucose, blood pressure control, 
avoidance of nerve and vasculotoxic agents and simple routine procedures have reduced 
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patient’s risk for amputation. These simple routine check-ups include daily inspection of 
the foot, wearing adequate footwear, extensive ulcer management and patient 
education(Apelqvist, Bakker, van Houtum, & Schaper, 2008). According to a previous 
report, effective preventive programs aiming at early detection and control of risk factors 
for foot ulceration and treatment with a multidisciplinary approach have reduced the rate 
for LEA by 49-85% (Apelqvist, Bakker, van Houtum, Nabuurs-Franssen, & Schaper, 
2000).   
1.1.4.2 Diabetic retinopathy 
Diabetic retinopathy (DR) is a characteristic complication of diabetes mellitus, marked by 
the degeneration of retinal vessels through inflammatory processes, neovascularisations 
and neurodegeneration(Xu et al., 2014). The risk of developing this manifestation 
increases with the duration of diabetes. In the Wisconsin Epidemiologic Study of 
Diabetic Retinopathy, 30 years after diagnosis, nearly all patients had some degree of 
retinopathy, and the prevalence of proliferative retinopathy (last and sight-threatening 
stage) was about 60%(Klein, Knudtson, Lee, Gangnon, & Klein, 2008). Retinal changes 
can be detected through ophthalmologic examinations and are classified as follows: 
a) background retinopathy 
b) preproliferative retinopathy and 
c) proliferative retinopathy  
Background retinopathy appears as ‘dots’ representing small haemorrhages in the retina. 
Haemorrhages together with microaneurysms indicate early stages of DR. ‘Hard 
exudates’ result from lipid depositions around the haemorrhages as signs of 
microvascular leakage. Hard exudates can endanger one’s vision if they get close to the 
macula. Microaneurysms (dilated retinal vessels) appear as red dots in funduscopy. 
Retinal oedema can appear at this stage through microvascular leakage and often needs 
treatment as it can cause visual impairment. Proliferative retinopathy clinically results in 
so-called ‘cotton wool spots’, indicating the formation of new vessels on the surface of 
the retina induced by elevated vascular endothelial growth factor (VEGF) expression as a 
response to vascular hypoxia. These new vessels are likely to be damaged, causing 
vitreous haemorrhages. The corresponding symptom is called ‘mouche volantes’. Repair 
mechanisms cause traction and consequently lead to the detachment of the vitreous body 
from the retina, resulting in one’s irreversible visual loss(Fowler, 2008). Diabetic 
retinopathy is the primary cause of blindness among adults between 20 and 74 years of 
age. Optimising glycaemic- (HbA1c ≤ 7 %) and blood pressure control (≤ 130 mmHg / ≤ 
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80 mmHg) has been demonstrated to decrease the progression and person’s risk for 
DR(Chew et al., 2010; ‘Tight blood pressure control and risk of macrovascular and 
microvascular complications in type 2 diabetes: UKPDS 38’, 1998). An ophthalmologist 
or optometrist should perform a comprehensive dilated eye examination initially; follow-
ups to detect any progress should be repeated annually. The rationale behind that is the 
option for laser photocoagulation surgery, which reduces the neovascularization induced 
by the hypoxia of damaged vessels. Neovascularization processes occurring at the retinal 
disc especially cause vision impairment and blindness and can be effectively prevented 
by laser photocoagulation surgery or pharmacological intervention with VEGF 
inhibitors(‘Preliminary report on effects of photocoagulation therapy. The Diabetic 
Retinopathy Study Research Group.’, 1976). 
 
1.1.4.3 Diabetic kidney disease 
Glomerulosclerosis, progressive albuminuria and declining glomerular filtration rate 
(GFR) are the histopathological and clinical correlates of diabetic kidney disease (DKD).  
Diabetic kidney disease is one of the leading causes of ESRD, which eventually requires 
renal replacement therapy. It is associated with high morbidity and mortality rates; 
according to the United States Renal Data System (2013), only 34% of patients receiving 
haemodialysis have survived the subsequent five years(Collins et al., 2014). The United 
Kingdom Prospective Diabetes Study (UKPDS) found that 10 years after diabetes onset, 
25% of patients had microalbuminuria (MiA). Of those patients with MiA, 30 to 45% 
progressed to MA over a 10-year period, and some of them reported progression despite 
stable glucose control(Caramori, Fioretto, & Mauer, 2000; Gross et al., 2005). Screening 
for diabetic nephropathy should start at the time of diagnosis, since approximately 7% of 
all patients with diabetes present symptoms of MiA at that time. Albumin excretion rates 
in a spot urine sample should be performed, as suggested by ADA guidelines, and re-
confirmed after three and six months if abnormal results are found. Furthermore, other 
causes of albuminuria need to be considered, and renal biopsy is the only measurement 
that can confirm DKD with certainty(Gross et al., 2005). However, the absence of clinical 
symptoms at early stages of DKD makes the condition more detectable at advanced 
stages. As a consequence, frequent screenings for renal impairment and control of risk 
factors are needed to prevent chronic kidney failure. Annual exams measuring urine 
albumin excretion rates and serum-creatinine levels are recommended in order to detect 
any decline in renal function. Additionally, risk factors for the progression of DKD 
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include hyperglycaemia, increased blood pressure levels, elevated serum lipid levels and 
tobacco consumption, all of which need to be reduced and controlled during each 
physician visit.  
 
1.2 Objectives - Systematic literature review  
Systematic literature research was conducted in order to determine the availability of 
epidemiological data on diabetes complications in Mexico and Central America. This 
served as a foundation for the subsequent analysis of Mexico. The aims of this systematic 
literature research were i) to review if population-based data exist for Central American 
countries; ii) to determine if these data were comparable to data from the Mexican Health 
and Nutrition Survey ENSANUT 2012); and iii) to compare the prevalence of diabetes 
complications in Mexico based on previous research that used data from the Mexican 
Health and Nutrition Survey 2012 (Encuesta Nacional de Salud y Nutrición, ENSANUT 
2012).  
To reach these aims, articles that contained information on the prevalence of diabetes 
complications in Mexico and Central America were retrieved, and diabetes complication 
prevalence was compared to results from Mexico.  
 
1.3 Search methods  
The database PubMed was systematically screened using mesh and search terms to match 
published documents with relevant information on diabetes complications. A 
reproducible stepwise approach was used to find relevant literature. During the first 
attempt, the mesh term search engine of the database PubMed helped us find synonyms 
for ‘diabetes complications’, ‘Central America’ and ‘Mexico’ to broaden the number of 
results. Each mesh term was numbered and systematically connected with the operators 
‘AND’ or ‘OR’, resulting in a smaller selection of search results. The mesh term 
‘diabetes complication’ in particular was connected with the mesh term of each country. 
For Central American countries, the search was restricted to population-based data only. 
Thus, clinical data were not considered. A more detailed literature review was performed 
for Mexico in order to guarantee uniqueness with regard to the topic for Mexico and gain 
an idea of the extent to which diabetes complication rates from clinical studies differed 
from observations of self-reported data from the ENSANUT 2012. We further reviewed 
 22 
the reference list of documents that found inclusion, which resulted in four additional 
references.  
The search was restricted to the years between 2000 and 2016, ensuring comparable data. 
For the same reason, documents created in the US were not considered, as migration and 
acculturation have diverse effects on health behaviour and outcome(Afable-Munsuz, 
Mayeda, Pérez-Stable, & Haan, 2013; Antecol & Bedard, 2006). Documents that 
provided epidemiological information on the following diabetes complications were 
included in our analysis: visual impairment caused by diabetes, DR and blindness, LEA, 
DKD/DN and ESRD requiring dialysis. 
Details concerning inclusion and exclusion criteria are displayed below. Table 1 and 
Table 2 present a detailed description of the search strategy. Due to the heterogeneity of 
populations and study designs, we did not conduct further statistic analyses of the results 
but limited the analysis to a descriptive comparison across retrieved documents.  
Inclusion criteria:  
1. Studies with data on diabetes complications of at least one complication caused 
by T2DM or where there was no distinction made between T2DM and T1DM  
2. Period: 2000 to 2015 
3. Studies with epidemiological data from Mexico or Central American (Guatemala, 
Nicaragua, El Salvador, Honduras, Belize, Costa Rica, Panama)  
4. English or Spanish language 
5. Full-text articles available 
Exclusion criteria: 
1. Mexican/Central-American emigrants residing in the US or in other countries. 
2. Studies that were conducted in the US or any country other than Mexico 
3. Diabetes mellitus due to secondary causes or aetiologies other than T2DM 
(gestational, early onset diabetes mellitus, etc.) 
4. Studies exclusively including patients with type 1 diabetes mellitus 
5. Patient cohorts where the diabetes prevalence was unclear 
6. Documents reporting the prevalence of a diabetes complication in patient cohorts 
referred from primary care units to specialised hospitals for screening (These 
documents were excluded because the selected cohorts had a complication 
prevalence of ideally nearly 100%. However, documents that were conducted in 
specialist centres with no prior selection through other health care practitioners 
were not excluded.)  
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Table 1. PubMed Mesh Term Search 
No. Componen
t 
[Mesh] 
Search term Hits First 
se-
lection 
Final 
se-
lection 
#1 Diabetes 
complicati
on 
"Diabetes 
Complications"[Mes
h] 
104,868   
#2 Mexican 
Americans 
Mexican American 
[MeSH Terms] 
3,361   
#3 Central 
Americans 
American Indians, 
Central [MeSH 
Terms] 
440   
#4 Central 
America 
Central America 
[MeSH Terms] 
11,915   
#5 Mexico Mexico [MeSH 
Terms] 
27,762   
#1 AND 
#2 
 ("Diabetes 
Complications"[Mes
h]) AND Mexican 
American [MeSH 
Terms] 
72 8 1 
#1 AND 
#3 
 "Diabetes 
Complications"[Mes
h]) AND American 
Indians, Central 
[MeSH Terms] 
1 0 0 
#1 AND 
#4 
 ("Diabetes 
Complications"[Mes
h]) AND Central 
America [MeSH 
Terms] 
15 5 0 
#1 AND 
#5 
 ("Diabetes 
Complications"[Mes
h]) AND Mexico 
[MeSH Terms] 
135 18 10 
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Table 2. PubMed Manual Search on diabetes complications in Mexico 
No. Search term Hits 
First 
Select
ion 
Final 
Selectio
n 
Additional 
documents1 
#1 Diabet* retinopathy AND Mexic* 218 25 7 1 
#2 Diabetic neuropathy AND Mexic* 148    
#3 Diabet* foot AND Mexic* 105    
#4 Diabet* amputation AND Mexic* 59    
#5 Diabet* nephropathy AND Mexic* 516    
#6 Diabet* kidney AND Mexic* 462    
#7 #2 OR #3 OR #4 224 16 5 2 
#8 #5 OR #6 516 39 6 1 
 
1 Additional documents that were found through screening of reference list of other documents 
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1.4 Results of the systematic literature review on diabetes complication in 
Mexico and Central America 
The search yielded 1,182 articles. A total of 16 documents were retrieved and are 
presented in Tables 3 through 6. A flowchart of the selection procedure of relevant 
articles is provided below (see Figure 1). No epidemiological information with national 
representative data for diabetes complications was found for Central America. Results for 
each analysed microvascular complication found for Mexico are presented below. 
Diabetic retinopathy 
The prevalence of DR ranged from 31.7% to 73.0% (see Table 3). The presentation of 
advanced stages of DR (Proliferative Diabetic Retinopathy, PDR) varied from 8% to 
81.4% among people with DR. Higher prevalence was found in studies that were 
conducted in specialised ophthalmologic clinics (73%(Cervantes-Castañeda, Menchaca-
Díaz, Alfaro-Trujillo, Guerrero-Gutiérrez, & Chayet-Berdowsky) and 51%(Rodríguez-
Saldana et al., 2010)) and in a study conducted in public hospital, where patients who 
have had diabetes for more than 10 years and whose median age was 60 years were 
included (68% (Cepeda-Nieto et al., 2015)).  
Lower prevalence was found in studies that were conducted in primary health care clinics 
or family medicine units of hospitals, where the data was collected by general physicians  
(27.5%(Sabag-Ruiz, Alvarez-Félix, Celiz-Zepeda, & Gómez-Alcalá, 2006), 
33.3%(Carrillo-Alarcón, López-López, Hernández-Aguilar, & Martínez-Cervantes, 2011) 
and 42.5% (Lavalle-Gonzalez et al., 2012)). In this analysis, DR was diagnosed either 
through (non-) dilated funduscopy, retrospective analysis of clinical charts or, as 
mentioned one document, based on self-report. A study by Polack et al. tested a screening 
tool for DR in a household survey setting using a probabilistic population-based study 
design. The study personnel visited households and assessed the presence of DR and 
blindness among patients with diabetes using fundus photography. They reported a 
prevalence of 38.9% for DR and 4.5% for blindness (Polack et al., 2012). Another study 
found that the prevalence of DR was about 10.4% among nine Latin American countries, 
including Mexico and Guatemala. In this study, general practitioners of each country 
were asked to fill out study questionnaires with information on patients with T2DM, 
including the presence of microvascular and macrovascular diabetes complications(Lopez 
Stewart et al., 2007). The proportion of self-reported DR in the ENSANUT 2012 was 
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13.9% of survey participants. Visual impairment was reported by 47.6% of participants 
and blindness by 6.6%.  
 
Diabetic neuropathy, diabetic foot ulcer and lower extremity amputation 
Six studies reported on the prevalence of DN, DF and LEA, see Table 4 Diabetic 
neuropathy, foot ulcer and lower extremity amputation in Mexico Three studies that were 
conducted in an outpatient family medicine unit belonging to IMSS/ISSSTE hospitals 
(tax-funded social security hospitals) found that the prevalence of DN was about 42.6% 
(Sabag-Ruiz et al., 2006), 54.5%(Camacho López, 2011) and 69%(Ibarra R, Rocha L, 
Hernández O, Nieves R, & Leyva J, 2012). One document from a primary care centre in 
Colima reported a prevalence of 27.1% for DN(Bañuelos-Barrera, Arias-Merino, & 
Banuelos-Barrera, 2013). The multicentre study conducted by Lavalle-Gonzalez et al. in 
2012 found a prevalence of DN of 62.8% (Lavalle-Gonzalez et al., 2012), and another 
study by Rodriguez-Saldana et al. (2010) assessed the prevalence of DN, DF and LEA by 
self-report of patients that attended specialised ophthalmologic clinics and found a 
prevalence of 25.8%, 10.5% and 3.8%, respectively (Rodríguez-Saldana et al., 2010). All 
documents provided data on the prevalence of DN (25.8%, 27.1%, 42.6%, 54.5%, 62.8 
and 69.0%), yet prevalence of DF was reported in only three out of six documents (2.4%, 
10.8% and 10.5%), and LEA rates were extracted from one document (3.8%). The 
prevalence of DN reported in the ENSANUT 2012 was about 42.6% across people with 
diabetes. Rates for DF and LEA were 7.2% and 2.0%, respectively.  
 
Diabetic kidney disease 
Diabetic kidney disease (also termed ‘diabetic nephropathy’) was common among 
patients with diabetes in all documents. Prevalence of DN ranged from 16% to 38%. 
Early nephropathy was reported in 40% to 85% of patients. Overt nephropathy was 
reported in one document at 29%. Different diagnostic measures were used. Two studies 
used the definition of the Kidney Disease Outcomes Quality Initiative (KDOQI), which 
defines ‘early nephropathy’ as MiA (urine albumin excretion rate = 30-300 mg/day) with 
normal GFR or absence of MiA and mildly decreased GFR (60-89 ml/min/1.73 m2). 
Macroalbuminuria (MA: urine albumin excretion >300mg/ day) and/or a GFR<60 
ml/min/1.73 m2) was defined as ‘overt nephropathy’. One study used information from 
self-reports, two from the attending specialist/physician, two from clinical trials and one 
was a community-screening program.  
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Three studies were conducted in IMSS hospitals: one was conducted in Coahuila using 
data from retrospective analysis of clinical charts (DKD=20.5%)(Sabag-Ruiz et al., 
2006), and two were clinical trials conducted in Sonora and Jalisco using dipstick urine to 
measure the presence of albuminuria and blood tests to asses creatinine levels for GFR 
calculations. These two latter documents reported a prevalence of 40% for early 
nephropathy, 29% for overt nephropathy and 20% for any kind of DKD as assessed by 
the attending physician (Cueto-Manzano et al., 2005; Leza-Torres, Briones-Lara, 
Gonzalez-Madrazo, De la Cruz-Martinez, & Ramos-Davila, 2005). One prospective study 
collected data from three major ophthalmologic hospitals in Mexico, and patients were 
asked to fill out forms that contained information on their history of DKD. This document 
reported the lowest prevalence for DKD with a rate of 15.9%(Rodríguez-Saldana et al., 
2010)One study was conducted as part of a community-screening program (Kidney Early 
Evaluation Program, KEEP) in Jalisco and Mexico City, where urine and blood samples 
were taken on-site. The level of urine-albuminuria as well as serum-creatinine was 
assessed to estimate GFR. Among people with diabetes, CKD was 38% in Jalisco and 
was three percentage points lower in Mexico City (Obrador et al., 2010). Similar results 
were found by the multicentre study by Lavalle-Gonzalez et al. (2012), with a prevalence 
of 37% (Lavalle-Gonzalez et al., 2012). Data from two rural primary health care centre 
reported lower rates of 23.8% (Zenteno-Castillo et al., 2015). 
Among ENSANUT 2012 participants, 1.4% of all individuals with diabetes suffered from 
ESRD and required renal replacement therapy. The ENSANUT 2012 data did not provide 
information on earlier stages of renal dysfunction and rates of MiA or MA. 
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Figure 1. Flowchart - Systematic literature research 
 
*DR = Diabetic Retinopathy, DN = Diabetic Neuropathy, DF = Diabetic Foot, LEA = Lower Extremity 
Amputation, DKD = Diabetic kidney disease 
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Table 3. Prevalence of diabetic Retinopathy in Mexico  
Author  Study 
perio
d 
Study 
place 
Study 
characteristics 
(N= counts; Age in 
years) 
Diagnosti
c measure 
DR 
prevalence* 
Mendoza
-Herrera 
et al. 
(2017)  
2014 
- 
2016 
Morelos, 
mobile unit 
screening 
in 3 low 
income 
municipalit
ies 
N(total) = 11468, 
 ≥ 20 years 
N(DM) = 1768 
Mean age = 57.2 
(SD = 11y) 
Female = 73%  
(Non-) 
dilated 
funduscop
y  
Overall: 31.7% 
NPDR = 59.6% 
PPR = 17.9% 
PDR= 22.5% 
Cepeda-
Nieto et 
al. (2015)  
n.a. IMSS 
hospital 
Saltillo,  
N(DM) = 177, 
patients with a 
previous diagnosis > 
10 years 
Median age = 60  
Female = 39% 
Non-
dilated 
funduscop
y 
Overall: 68% 
NPDR = 41.3% 
PDR = 58.7% 
Jimenez- 
Baez et 
al. (2015)  
n.a. Quintana 
Roo, eight 
IMSS 
primary-
care units 
N(DM) = 105 
Women = 55% 
Mean age = 48 
(SD=11.1) 
Dilated 
funduscop
y 
Overall: 23.8% 
NPDR = 92.0% 
PDR = 8% 
Cervante
s-
Castaned
a et al. 
(2014)  
2006 
- 
2010 
Baja 
California, 
Ophthalmol
ogy Centre 
Tijuana, 
retrospectiv
e analysis 
N(DM) = 500 
Mean age = 57.7 
(SD=11.0) 
Informatio
n from 
clinical 
charts 
Overall= 
73.0% 
NPDR = 18.6% 
PDR = 81.4% 
Polack et 
al. (2012)  
2010 Chiapas, 
population 
representati
ve study  
N = 1974 
N(DM) = 347 
Dilated 
fundus 
photograp
hs 
Overall= 
38.9% 
Severe DR= 
21.0% 
Blindness = 
4.5% 
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Rodrígue
z-Saldana 
et al. 
(2010)  
2001-
2007 
Mexico 
City, three 
ophthalmol
ogy 
hospitals 
N(T2DM) = 1000 
Mean age= 60.5  
Female = 61.1% 
Self-report Overall= 
51.1% 
Blindness = 
16.3% 
Sabag-
Ruiz et 
al. 2006  
2001 
- 
2002 
Sonora, 
family unit 
in Obregón 
City, 
retrospectiv
e analysis 
N(DM) = 250 
Mean age = 59.3 
(30-87 years) 
Clinical 
charts, 
diagnosed 
by an 
Ophthalm
ologist 
Overall: 27.5% 
PPR = 14.3% 
PDR = 85.7%  
Carillo-
Alarcón 
(2011)  
2010 Hidalgo, 
five 
primary 
health care 
centre  
N(DM) = 117 
Mean age = 58.1 
(SD=11.1) 
Female=77.8% 
Dilated 
funduscop
y  
Overall 33.3% 
NPDR = 89.8% 
PDR = 10.2% 
Lavalle-
Gonzalez 
et al. 2012  
2007 Mexico, 
physicians 
from 32 
states, 
prospective
, 
multicentre 
study 
N(T2DM) = 2439 
N(T1DM) = 203 
Female = 60% 
Mean: 56.7% 
Ophthalm
ologists 
diagnosed 
presence 
of DR 
Overall: 42.5% 
DR = Diabetic Retinopathy 
Overall = Prevalence of any severity level of diabetic retinopathy  
NPDR = Non-proliferative Diabetic Retinopathy 
PPDR = Pre-Proliferative Diabetic Retinopathy 
PDR = Proliferative Diabetic Retinopathy 
IMSS = Instituto Mexicano del Seguro Social (Social Security, tax-funded health care)  
T2DM = Type 2 Diabetes Mellitus 
T1DM = Type 1 Diabetes Mellitus 
SD = Standard Deviation 
n.a. = not available 
*Prevalence of DR stages (NPDR/PDR) was reported as % of the total DR prevalence  
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Table 4 Diabetic neuropathy, foot ulcer and lower extremity amputation in Mexico  
Author  Study 
period 
Study place Study characteristics 
(Age in years) 
Diagnostic 
measure 
Prevalence 
DN/DF/LEA*  
Banuelos-
Barrera et 
al. 2013  
2012 Colima,  
Primary care 
centre  
N(T2DM) = 87  
Mean age: 58.8  
>30 years (SD=12.2) 
Female = 70.1% 
Semmes-
Weinstein 
monofilament 
test 
 
DF ulcer: 
2.4% 
DN: 27.1% 
PVD#: 52.4% 
 
Ibarra R et 
al. 2012  
n.a. Guanajuato,  
Outpatient 
Family medicine 
unit (IMSS 
institute **) 
N(T2DM)=348 
Mean age: 58 
Diabetes  
duration: 5-15y 
Female: 60% 
Michigan 
Neuropathy 
Screening 
Instrument 
DN: 69% 
Camacho 
López 
2011  
n.a. Sinaloa, 
Outpatient 
Family medicine 
unit (ISSSTE 
institute**) 
N(T2DM) = 207 
Female: 59% 
Mean age: 59 
(SD=12.5) 
Neuropathy 
Symptoms 
Score 
DN: 54.5% 
Sabag-
Ruiz et al. 
2006  
2001-
2002 
Sonora, Family 
medicine unit 
(IMSS institute)  
N(T2DM) = 168 
Female: 64.9% 
Physician 
diagnosis, no 
further 
information 
available 
DN = 42.6% 
DF: 10.8% 
Lavalle-
Gonzalez 
et al. 2012  
2007 Mexico, 
physicians from 
32 states, 
prospective, 
multicentre study 
N(T2DM) = 2439 
N(T1DM) = 203 
Female = 60% 
Neurologists 
diagnosed 
presence of 
DN/PVD 
DN = 62.8  
 
Rodríguez-
Saldana et 
al. (2010)  
2001-
2007 
Mexico City, 3 
ophthalmologic 
hospitals 
N(T2DM) = 1000 
Mean age= 60.5  
Female = 61.1% 
Data obtained 
from self-
report  
DF = 10.5% 
DN = 25.8 
LEA = 3.8% 
* DN = Diabetic neuropathy; DF = Diabetic Foot; LEA = Lower Extremity Amputation 
**IMSS and ISSSTE = Social Security, tax-funded health care 
# PVD = Peripheral Vascular Disease 
SD = Standard deviation, T2DM: Type 2 diabetes mellitus 
no
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Table 5. Prevalence of diabetic kidney disease (DKD) in Mexicans with diabetes 
Author  Study 
period 
Study place Study 
characteristics 
(Age in years) 
Diagnostic 
measure 
Prevalence 
of DKD  
Zenteno-
Castillo et 
al. 2015  
2010-
2011 
Guanajuato, 
data from 2 
rural primary 
health care 
centres 
N(T2DM) = 335 
Female 
Mean age = 69.3 
(SD=11) 
Kidney Disease 
Outcomes Quality 
Initiative 
 
23.8% 
Lavalle-
Gonzalez 
et al. 2012  
2007 Mexico, 
physicians 
from 32 states, 
prospective, 
multicentre 
study 
 
N(T2DM) = 2439 
N(T1DM) = 203 
Female = 60% 
Nephrologists 
diagnosed 
presence of 
diabetic 
nephropathy 
37.3% 
Rodríguez-
Saldana et 
al. (2010)  
2001-
2007 
Mexico City, 3 
specialised 
ophthalmologi
c hospitals 
 
N(T2DM) = 1000 
Mean age= 60.5  
Female = 61.1% 
Self-reported 
history of diabetic 
nephropathy  
15.9% 
Obrador 
et al. 2010 
2008 -
2009 
Mexico and 
Jalisco; 
Community 
screening 
program  
 
N(DM) Mexico = 
425 (28%) 
N(DM) Jalisco = 
808 (44%) 
On-site urine and 
blood sample tests  
Mexico = 
35% 
Jalisco = 
38% 
Sabag-
Ruiz et al. 
2006  
n.a. Sonora, Family 
medicine unit 
(IMSS 
institute*) 
N(DM) = 252 
Female = 64.9% 
Mean age = 59.3 
(30 - 87yrs) 
Retrospective 
analysis, 
Information from 
clinical charts 
20.5%  
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Leza-
Torres 
2005  
2004 Coahuila, 
IMSS hospital  
N(T2DM) = 301 
female = 59.0% 
mean age = 57.2 
(SD = 10.9) 
Urine and blood 
sample 
MiA** = 
85.3% 
MA = 
11.5% 
 
Cueto-
Manzano 
et al. 2005  
n.a. Jalisco, 3 
primary care 
medical units  
N(T2DM) = 756 
Mean age: 54 (SD=10) 
female = 65% 
Urine and blood sample 
DKD definition: Kidney Disease 
Outcomes Quality Initiative (KDOQI) 
 
MiA** / 
GFR 60-89 
ml/min = 
40% 
MA / 
GFR<60ml/
min) = 29% 
*IMSS = Instituto Mexican de Salud Social (Social Security, tax-funded health care)  
**MiA = Microalbuminuria; MA = Macroalbuminuria; GFR= Glomerular Filtration Rates 
T2DM = Type 2 Diabets mellitus, DM = Diabetes Mellitus 
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1.4.1 Discussion 
The rising incidence and prevalence of diabetes complications are economically 
challenging health systems in Latin America(van Dieren, Beulens, van der Schouw, 
Grobbee, & Neal, 2010). This trend has been observed over a long period of time; 
however, we could not find epidemiological and nationally representative data on the 
prevalence of diabetes complications in Central America. We found epidemiological 
data on microvascular complications that were representative of the entire population 
exclusively for Mexico. Although Costa Rica and Panama regularly conduct national 
health and nutrition surveys, no reports on diabetes complications were available. 
Similar to prior epidemiologic investigations into microvascular complications, we 
found limitations with respect to a lack of consensus on the classification of 
microvascular complications, severity levels and the definition of the surveyed 
population (population with T1DM or T2DM and those with risk factors versus the 
general population with diabetes)(Kvitkina et al., 2015). The following section intends 
to critically review these differences with regard to the level of comparability of 
information obtained from the ENSANUT 2012 (Gutierrez et al., 2012). 
Diabetic retinopathy in Mexico:  
We compared documents with information on the prevalence of microvascular diabetes 
complications that were conducted in households or at the community level, in primary 
health care clinics, in general and specialised clinics with data from the ENSANUT 
2012 survey.  
The prevalence of DR was substantially lower in the ENSANUT 2012 compared to 
other studies (13.9% vs. 31.7%-73.0%,). The most comparable document was a 
population-based study by Polack et al. conducted in 2010 in the state of 
Chiapas(Polack et al., 2012). Similar to the ENSANUT 2012, a clustered household 
survey design was applied. The prevalence of DR was assessed through fundus 
photography conducted in the households of survey participants. The authors found that 
DR was prevalent in 38.9% of all participants, which was more than twice as high 
compared to the prevalence of DR in ENSANUT 2012. The prevalence of blindness 
caused by diabetes was higher in ENSANUT, at 6.6% compared to 4.5% in Polack et 
al., which is surprising because Chiapas is the state with the lowest socioeconomic and 
developmental profile among the Mexican states(Instituto Nacional de Estadistica y 
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Geografía, 2014). People from lower socioeconomic levels are more likely to present 
advanced stages of microvascular diabetes complications, particularly diabetes-acquired 
blindness caused by delayed surgical and pharmacological intervention(Funakoshi et 
al., 2017).  
Other documents presented higher rates for DR; however, the study design and the 
population differed substantially from ENSANUT 2012. For example, a multicentre 
study conducted in all 32 states of Mexico by Lavalle-Gonzalez et al. (2012) reported a 
prevalence of 42.5%(Lavalle-Gonzalez et al., 2012). The data for this study were 
collected by general practitioners using case report forms. However, the higher 
prevalence of diabetes complications in this study could be due to selection bias. 
Similarly, the significantly high prevalence of 68% found by Cepeda-Nieto et al. (2015) 
might be explainable by the older age and selection criteria of patients who had diabetes 
for at least 10 years or more. In the US, approximately 29% of survey participants with 
diabetes from the American Health and Nutrition Examination (NHANES) presented 
any degree of DR, which is still about 15% higher than in the ENSANUT 2012 (Zhang 
et al., 2010). In summary, specialised ophthalmologic clinics found the highest 
prevalence of DR, followed by multicentre studies, the population-based study by 
Polack et al. and data that were retrieved from family medicine units. Considering the 
high discrepancy in the prevalence of DR in Mexico, we can assume that DR in the 
ENSANUT cohort is fairly underestimated. We expect that many respondents with DR 
did not know about their diagnosis, either because they were not diagnosed or were not 
familiar with the medical term. These respondents could be found in the ‘vision 
impairment group’, which was prevalent in 47.6% of all people with diabetes. However, 
whether the cause of the vision impairment was DR or any other sight affecting 
condition (e.g. diabetic maculopathy) is uncertain. Consequently, the actual prevalence 
of DR is assumed to be between 14% and 40%, as results from the systematic literature 
research suggest. These findings point out the difficulty of estimating the prevalence of 
diabetes complications based on self-reported data. In order to increase the quality and 
reliability of the complication prevalence it would be necessary to use diagnostic tests 
(such as blood- or ophthalmologic tests). However these are expensive in large 
population based surveys, which limits the feasibility of such tests in population based 
surveys(Mendoza-Herrera et al., 2017). 
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Diabetic neuropathy, diabetic foot ulcer and lower extremity amputation: 
Studies that were included in this systematic literature review reported a prevalence of 
DN between 25.8% and 69.0% The diagnostic measures used included the Semmes-
Weinstein monofilament test, the Michigan Neuropathy Screening instrument, the 
Neuropathy Symptom score, self-reported data or a specialist opinion that diagnosed the 
presence of DN. For comparison, 42.6% of respondents with diabetes from ENSANUT 
2012 reported a history of numbness or burning in the soles of the feet, indicative of 
DN. Aside from the report by Sabag-Ruiz et al. (DN = 42.8%) and Rodriguez-Saldana 
et al. (DN = 25.8%), results of the systematic literature research suggest higher rates of 
DR compared to the ENSANUT data for DN. The low prevalence in Rodriguez-
Saldana et al. might be a result of the patient cohort and setting. In this case, DN was 
observed to be comorbid in patients who initially attended an ophthalmologic centre 
because of vision impairment. Although Sabag-Ruiz et al. reported similar rates for DN 
compared to ENSANUT 2012, it is likely that the prevalence of DN is actually higher 
than reported because patients might actually have DN without presenting the typical 
burning or sensation of pain in the foot or soles. However, it is noteworthy that almost 
half of all patients with diabetes in ENSANUT reported this symptom and were thereby 
at higher risk of developing foot ulcerations. Compared to the prevalence found in the 
Latin American region (DN = 15.5%), the high rate in Mexico gave reason for concern. 
However, this prevalence found in the Latin American region must be considered with 
caution as general practitioners in several Latin American countries reviewed patient 
charts over a two-week period and collected data from the first 8 to 12 patients with 
T2DM who sought consultation. The history of diabetes complications in patient charts 
might be incomplete, and it is not certain whether the participating physicians 
completed a full screening to detect any complication in those 8 to 12 patients. This 
may explain the overall lower prevalence of diabetes complications in this document. 
According to estimations from a landmark study with 4.400 patients evaluated over 25 
years, about 50% of all people developed some form of DN(Pirart, 1978).  
With regard to DF, only few a few reviews provided epidemiological information. One 
of the reasons is that DF is usually measured through hospital discharge letters for cost 
estimations and not for prevalence rates. However, these few documents reported that 
the prevalence of foot ulcers ranged from 2.4% to 10.8%, compared to 7.2% of patients 
with diabetes in ENSANUT 2012. The yearly prevalence of DF in the US was 
consistent with ENSANUT 2012 findings: in 2008, 8% of Medicare beneficiaries with 
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diabetes had a history of a DF and 1.8% had LEA(Margolis et al., 2011). Lower 
extremity amputation in ENSANUT 2012 was reported in 2.0% of all cases of diabetes 
and was lower in the Latin American Region (0.9% of all survey participants). It is 
noteworthy that the prevalence of DF in self-reported data has likely been 
underestimated. In the National Health Interview survey conducted in the US, self-
reported data on DF were considered to underestimate the actual prevalence by one 
third(Margolis et al., 2011). Similar or even higher estimations can be expected for the 
cohort surveyed in ENSANUT 2012.  
 
Diabetic kidney disease:  
Diabetic kidney disease (DKD), also termed diabetic nephropathy (DN) is 
glomerulopathy caused by metabolic and hemodynamic alterations. Diabetic kidney 
disease is the leading cause of renal failure in most populations(Reutens, 2013), and 
approximately one third to one half of patients with diabetes develop DKD of any stage  
(De Boer, 2014). However, estimating the prevalence of DKD is difficult. First, a 
definite diagnosis can solely be confirmed by renal biopsy, which is performed only if 
the diagnosis remains unclear. Second, while diabetes might be the underlying cause for 
most cases of DKD, other comorbid diseases potentially confound the prevalence. For 
example, non-diabetic renal disease in patients with diabetes was reported in 27% to 
79% of patients(Park, 2014). Furthermore, no uniform diagnosis criteria and screening 
method for DKD exists because established methods have shortfalls when it comes to 
confirming DKD. In most epidemiological studies, screening for DKD uses urine 
albumin excretion rates from 24-hour urine collections, albumin-creatinine ratios and/or 
estimated glomerular filtration rates (GFR)(De Boer, 2014). However, GFRs naturally 
decrease with increasing age without causing any abnormality in albumin excretion 
rates(Stanton, 2014). Even so, the use of MiA screening with urine dipsticks has 
recently been questioned due to the process’ low sensitivity and specificity in predicting 
kidney outcomes. In this regard, the paradigm of irreversible progress from MiA to MA 
and then chronic renal failure has been disproved, and spontaneous remission to normal 
kidney function has been observed at any stage at the occurrence of 
proteinuria(Maclsaac, Ekinci, & Jerums, 2014). This has led to differences in the 
definitions of DKD and has had implications on screening methods for DKD. The 
Kidney Disease Outcomes Quality Initiative (KDOQI) guideline suggests that DKD is 
likely if persisting albuminuria in combination with arterial hypertension and declining 
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GFRs exist in patients with diabetes(Parving, Persson, & Rossing, 2015). As for this 
research, DKD was considered based on self-report, clinical diagnosis or the presence 
of MiA or MA. The diagnosis was highly variable and ranged from 15.9% to 38.0%. 
Self-reported data reported a lower prevalence of 15.9% (Rodriguez-Saldana et al. 
2010), whereas nephrologists in the multi-centre study conducted by Lavalle-Gonzalez 
et al. (2012) found a prevalence more than twice as high (37.3%). Similar results were 
found in the community screening program: 35% of diabetes patients from Mexico City 
and 38% from Jalisco presenting chronic kidney disease(Obrador et al., 2010). The 
ENSANUT 2012 only reported the necessity for renal replacement therapy among 
people with diabetes. Accordingly, the prevalence of DKD in the ENSANUT 2012 was 
lowest due to the exclusion of earlier stages of DKD and accounted for only 1.4% of 
people with diabetes. One of the reasons for this exclusion might be that self-reporting 
of earlier stages of DKD is an inadequate measure, as decreased kidney function can be 
compensated for by other organs and can remain symptomatically silent over a long 
period of time. Additionally, screening for MiA or MA is infrequently performed for 
patients with T2DM, resulting in a large number of unreported cases. For example the 
Kidney Early Evaluation Program (KEEP), a free community screening program 
conducted in Jalisco and Mexico City observed concerning results: 35% to 38% of the 
screened participants with diabetes were diagnosed with DKD, 1% of the participants in 
Mexico City were aware of the diagnosis although 71% of them reported they had been 
seen by a physician in the previous year. In Jalisco, none of the study participants with 
DKD knew about their diagnoses(Obrador et al., 2010). 
Certainly, ESRD is the most expensive consequence of diabetes, leading to more 
disabilities and death compared to other diabetes complications(Barquera et al., 2013). 
Although it is also the least prevalent diabetes complication, it is estimated that end 
stage renal disease will become an increasing trend in the future. It is likely that the 
demand for renal replacement therapy will rise(Alegre-Diaz et al., 2016). As opposed to 
other Latin American countries, Mexico does not provide universal access to dialysis, 
and renal replacement therapy was not equally available throughout the country. 
According to García-García et al. (2005), renal replacement therapy was at the time of 
the study only accessible to the insured population. However, the poor population was 
severely underserved. In this study conducted shortly after the implementation of 
universal public health care (‘Seguro Popular’), half of the studied population with 
chronic kidney disease was uninsured and had access to eight haemodialysis stations, in 
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comparison to the insured population, which had access to 34 stations. Furthermore, 
poor people were found to be receiving dialysis therapy at a later point compared to 
those with better socioeconomic backgrounds(Garcia-Garcia et al., 2005). This shortfall 
may have been improved since the implementation of universal public health care 
(‘Seguro popular’); however, the exact number of people with diabetes suffering from 
DKD remains unclear, and it is conceivable that renal failure is the cause of premature 
death in many underserved communities. Furthermore, microvascular diabetes 
complications, DKD and other similar complications are preventable. Increased 
prevalence of complications is indicative of delayed diagnoses, treatment and 
insufficient prevention and provision of diabetes care.  
In conclusion, we found no existing information on microvascular diabetes 
complications representative of the Central American countries. Only Mexico was 
found to have assessed diabetes complication rates in the form of the National Health 
and Nutrition Surveys, which provide high-quality data and provide a valuable tool for 
estimating the burden of diabetes complications in a nationally representative sample 
(Barquera et al., 2013). However, these data rely on self-reporting, which leads to 
uncertainty in terms of the accuracy and validity of the underlying medical 
diagnosis(Short et al., 2009). Documents that were obtained to compare clinical data on 
complication prevalence in Mexico to ENSANUT 2012 data were heterogeneous in 
terms of study design and studied population. The prevalence of diabetes complications 
was high for Mexicans, and clinical data reported higher prevalence of DR and partially 
for the prevalence of DKD and DF compared to the data provided by ENSANUT 2012. 
The most comparable element was DR. Although the populations differed, the 
diagnostic measure was similar between all documents, except for the document by 
Rodriguez-Saldana et al. who assessed DR based on self-reports. Diagnostic 
comparability is expected even for information from clinical charts because dilated or 
non-dilated funduscopy was the established method for assessing DR at the time. 
Clearly defined diagnosis criteria were available for DR and were identical across the 
studies. The document provided by Polack et al. was especially valuable for estimating 
the discrepancy between self-reported data from ENSANUT 2012 and information 
obtained through funduscopy with a comparable study setting. The comparison suggests 
that the prevalence of DR was 2.8 times higher in information obtained through 
funduscopy compared to self-reported data. Therefore, it is likely that other 
complications in the ENSANUT were similarly underestimated. However, the lack of 
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comparability between documents only allows for approximations, and comparisons 
should be made with caution. The implementation of a central diabetes register, where 
medical records on the history of diabetes, comorbidities, complications, treatments, 
physician follow-ups, and other documents are filed, and similar studies to the one by 
Polack et al. could markedly improve data availability and validity. Finally, it is 
important to mention that the results presented in this dissertation are not exhaustive 
and rather serve to provide a general impression of the availability and quality of data in 
Mexico and Central America.  
In the following section, we conduct a detailed analysis of the epidemiology, risk 
factors and spatial distribution of diabetes complications, as well as describe the 
utilisation of preventive measures in rural and urban areas of Mexico using the Mexican 
National Health and Nutrition Survey (ENSANUT 2012). 
2 PART II: Diabetes complications in Mexico 
2.1 Introduction 
2.1.1 Epidemiology of Type 2 Diabetes Mellitus in Mexico 
Mexico has experienced a fast epidemiological transition in the past decade. In 
comparison to all OECD nations, Mexico has demonstrated the strongest development 
in recent years. With this improvement, a shift in the high prevalence of infectious 
diseases and undernutrition to a high prevalence of non-communicable diseases took 
place. Along with urbanisation and development came changes in dietary and physical 
activity patterns, leading Mexico to experience the largest increase in obesity and 
diabetes ever recorded worldwide(Barquera et al., 2008). Nationally, non-
communicable diseases caused 75% of total deaths and 68% of total Disability Adjusted 
Life Years (DALY), and 9.7% of deaths were attributable to diabetes(Stevens et al., 
2008). The results of National Health and Nutrition Surveys in Mexico suggested a rise 
in the prevalence of diabetes over the past several decades. In the first national health 
survey, conducted in 2000, the prevalence of previously diagnosed diabetes was about 
5.8%. This increased to 7.3% in 2006, along with an additional 7.1% of people with 
undiagnosed diabetes that were screened during the survey, making the total prevalence 
14.4%(Villalpando et al., 2010). Results from ENSANUT 2012 suggested that the 
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prevalence of diabetes was 9.2%, without taking undiagnosed cases into 
account(Hernández-Ávila, Gutiérrez, & Reynoso-Noverón, 2013). No national 
incidence rates for diabetes in Mexico have been published. However, Meza et al. 
(2015) estimated an exponential increase during 1960 and 2012, with rates doubling 
every 10 years(Meza et al., 2015). With regard to the age of onset of diabetes, people in 
developing countries are diagnosed with diabetes between 45 and 64 years of age, while 
a majority of people from developed countries are diagnosed with diabetes over the age 
of 64 (Wild, Roglic, Green, Sicree, & King, 2004). This predicts the development of 
diabetic complications, with diabetes duration and glycaemic control being the most 
relevant risk factors(Knuiman, Welborn, McCann, Stanton, & Constable, 1986). As 
outlined beforehand, diabetes complications are frequently found in patients with 
diabetes in Mexico (Results from the systematic literature research: DR: 32 – 73%; DN: 
26 - 69%; DF: 2 – 11%; DKD: 16 -38%), and social determinants have relevant effects 
on the utilisation of preventive measures(Walker, Smalls, Campbell, Strom Williams, & 
Egede, 2014). Certain factors, such as socioeconomic disadvantage, health care access 
and demographic characteristic, predispose people to lower treatment adherence and 
glycaemic control. Additionally, people from low- and middle- income countries are 
often referred to specialised centres when diabetes complications reach irreversibly 
advanced stages, leading to financial impacts on individuals and health 
systems(Barquera et al., 2013; Cervantes-Castañeda et al.).  
2.1.2 The economic burden of diabetes complications in Mexico 
In 2010, diabetes ranked 11th among the main reasons for hospitalisations and was 
increasing hospital stays by 2.6 days compared to other diseases(Rull et al., 2005). 
Arredondo and Reyes (2013) calculated the direct and indirect costs of diabetes in 2011 
in Mexico. The direct costs of diabetes were primarily due to prescribed anti-diabetic 
medication, followed by outpatient care (consultations) and hospitalisation. Twenty-
four percent of all direct costs were spent on DKD, 3% on DR, 0.8% on DN and 0.5% 
on peripheral vascular disease. Indirect costs represented 56 % of the total cost of 
diabetes mellitus in Mexico in 2011, and costs arising due to permanent handicap made 
up for 93% of all indirect costs followed by premature mortality (5%) and temporary 
handicap (2%)(Arredondo & Reyes, 2013). Once diabetes complications appeared, the 
annual average diabetes cost increased by 75% for DN, 13% for vascular complications, 
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8% for retinopathy and 3% for neuropathy(Barquera et al., 2013). Arredondo and Reyes 
pointed out that the majority of all costs arose from the indirect costs, with permanent 
handicap and chronic renal failure in particular being the most expensive factors of all 
arising costs. This is particularly problematic considering that an increasing trend 
towards early onset diabetes has been observed in recent years in Mexico. In 1993, 
1.8% of the population at or above 40 years of age had diabetes. This prevalence 
reached 2.3% in 2000(Olaiz-Fernández, Rojas, Aguilar-Salinas, Rauda, & Villalpando, 
2007) and 5.7% in 2006(Jimenez-Corona, Rojas, Gomez-Perez, & Aguilar-Salinas, 
2010). Economically, patients with early onset diabetes have an increased risk of 
developing disabling diabetes complications at a younger age, which reduces 
productivity and employment chances compared to those who experience complications 
at an older age(Seuring, Goryakin, & Suhrcke, 2015). Also people that work in the 
informal sector (approximately 58% in 2005) rely on their income even at older age due 
to the lack of financial security and health care coverage. (Aguila, Diaz, Fu, Kapteyn, & 
Pierson, 2011).  
Although out-of-pocket-payments in Mexico have been reduced by 12.6% since 2009, 
they remain high, making up 41% of all health spending in 2016, and are twice as high 
compared to the OECD average(OECD Organisation for Economic Coooperation and 
Development, 2017). Accordingly, Mexican households can afford approximately 50% 
of all costs, and only 45% of the medical expenses required to manage diabetes are 
covered by the government(Arredondo & Reyes, 2013). Taking all these factors into 
account, preventive medicine in patients with diabetes has gained importance in 
Mexican health policy and should be cost-effective at all stages of diabetes. According 
to Castro-Ríos et al. (2010), each US dollar spent on prevention would save $84 to $323 
over a 20-year period(Castro-Rios, Doubova, Martinez-Valverde, Coria-Soto, & Perez-
Cuevas, 2010).  
Public health care, ‘Seguro Popular’ (SP), covers a large part of the needs of the 
Mexican population with diabetes and those with diabetes complications. People that 
are insured by SP largely represent the formerly uninsured population, the unemployed 
population and people working in the informal sector with lower economic resources. 
Prior to the implementation of SP in 2003, almost half of the population did not have 
any health insurance(Sosa-Rubí, Galárraga, & López-Ridaura, 2009). While Social 
Security (SS) is equally funded by the employee, the employer and the government, SP 
(public health care) is fully or partially subsidised by the government depending on a 
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person’s employment status(Dantés et al., 2011). Consequently, states and areas where 
there are high prevalence of diabetes and high complications rates and where large 
proportions of SP affiliates or uninsured patients live rely more on public funding to 
cover the health care needs of the population (Davidson, Andersen, Wyn, & Brown, 
2004; OECD Organisation for Economic Coooperation and Development, 2016b).  
2.1.3 Geographical differences of diabetes outcome  
Geographic analysis of illness patterns helps to establish public health interventions 
aimed at monitoring and controlling communicable diseases where these are most 
required. Geographic disparities in diabetes outcomes have been observed in prior 
studies. In the US, DF and amputation is clustered in neighbouring areas. Areas with 
high rates of LEA were associated with lower socioeconomic statuses, African 
American ancestry and higher mortality from DF(Margolis et al., 2011). Observations 
in Mexico suggest that diabetes mortality differs across regions. In a document from 
1995, Escobedo and Santos found that states situated in the north and the federal district 
of Mexico had higher diabetes mortality rates compared to southern states(Escobedo-de 
la Pena & Santos-Burgoa, 1995). However, diabetes mortality in southern states 
increased by 128% from 1980 to 2000, compared to the northern region where mortality 
rates only increased by 32.5%(Barquera et al., 2013). Stevens et al. (2010) explain 
mortality disparities with regional differences in regard to the current epidemiological 
transition stage. According to their results with data from 2010, the southern region was 
the least developed region and, at the earliest transitional stage, was facing a double 
burden of pre-transitional diseases (e.g. infectious disease, malnutrition, etc.). This 
region simultaneously had the highest burden of chronic non-communicable disease 
(Diabetes mellitus, Cardiovascular disease, etc.) per capita. In comparison, the northern 
and the Pacific Central region reflected the highest level of social and economic 
development with an epidemiological transition profile of high-income nations(Stevens 
et al., 2008). The southern region and the Yucatán peninsula have the highest 
proportion of indigenous communities. While the Yucatán peninsula has largely 
benefitted from tourism in recent years, the states to the south have not benefited from 
equivalent economic resources and lag behind in structural development. All of these 
factors contribute to the heterogeneous socioeconomic patterns associated with 
differences in diabetes outcomes. The description of regions in this analysis refers to the 
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regions established by Stevens et al. in 2010 (see Figure 2 below).  
Figure 2. Regions of Mexico 
 
2.1.4 Diabetes in rural and urban areas 
Similar to interstate disparities with regard to diabetes outcomes, urban and rural 
localities differ concerning the prevalence of diabetes and diabetes complications. 
However, inconsistent results from prior research indicate that rural-urban differences 
regarding the prevalence of diabetes and diabetes-related complications are bound to 
context. For example in Mexico, the prevalence of diabetes was higher in urban areas 
compared to rural areas in 2000 (10.4% vs. 5.6%, resp.) and in 2006 (15.5% vs. 8.2%, 
resp.) (Barquera et al., 2008). Yet, in a cross-sectional study in the US using data from 
the Behavioral Risk Factor Surveillance system (BRFSS), the prevalence of diabetes 
was 8.6% higher among rural respondents due to increased rates of poverty, obesity and 
tobacco use among the rural population living in the US(O’Connor & Wellenius, 2012). 
Likewise, rural residents in the US reported higher rates of DR compared to urban 
residents (25.8% vs. 22.0%, p=0.007) in the BRFSS 2006(Hale, Bennett, & Probst, 
2010). Additionally, in China, DR was more prevalent across rural regions (29.1–43.1 
%) compared to urban areas (18.1%), most likely because of inadequate screening 
techniques and care for diabetes in rural areas. Conversely, the prevalence of DR in 
Mexican regions based on geographic proximity and similarity over several indicators, 
including a deprivation index, per capita GDP, and overall mortality levels (from Stevens et 
al., 2010 (Stevens et al., 2008)) 
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India was higher in urban areas (18.0% in urban vs. 10.8% in rural areas), potentially 
due to selective mortality of people with diabetes complications in rural India(Lee, 
Wong, & Sabanayagam, 2015). In rural areas of Mexico, access to and quality of 
diabetes care was reported to be considerably lower. According to Salinas et al., in 
2011, older Mexicans living in rural areas were less likely to have health care coverage 
and health care services were difficult to access(Salinas, Al Snih, Markides, Ray, & 
Angel, 2010). Lower physician and specialist densities, resulting in larger travel 
distances for patients, also limited access to health care. For example, in the federal 
district in Mexico, the physician density was 3.9 per 1000 inhabitants, whereas Chiapas 
and Puebla, states with large rural areas, had a physician density of 1.3 per 1000 
inhabitants in 2013(OECD Organisation for Economic Coooperation and Development, 
2016a). Furthermore, socioeconomic differences between rural and urban areas resulted 
in catastrophic health expenditures that were 3.5 times higher in rural Mexico compared 
to urban households(Knaul et al., 2011). In order to explore the effects of locality on the 
development and progression of diabetes complications, we established a framework to 
structure the subsequent analysis.  
2.2 Analytical framework – Access to diabetes care  
As suggested by previous research, we viewed geographical differences considering the 
development of diabetes complications as resulting from the decreased participation of 
individuals in diabetes complication screenings and subsequent insufficient blood 
glucose control. Access to health care or, in this case, diabetes care, has been previously 
defined based on the need for services. This concept relies on the availability and 
affordability of services as well the ability to receive health services and to receive 
health care that is appropriate to the needs of the patient. This also further implies that 
patients understand the advantage of preventive measurements(Levesque, Harris, & 
Russell, 2013). We adapted the previously established framework of Peters et al. (2008) 
in ‘Poverty and Access to Health Care in Developing Countries’ to fit univariate and 
multivariate models for the use of the ENSANUT 2012 data(Newman et al., 2015). This 
approach simplifies the complex set of interactions among patients and providers and 
explores factors that lead to geographical disparities in diabetes outcomes (see Figure 
3). In our model, performance of diabetes screening and follow-ups was used as a 
parameter to measure access to diabetes care. The model is based on three main 
dimensions of access: i) geographic accessibility; ii) availability; and iii) financial 
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accessibility. In this model, geographic accessibility depends on the user and service’s 
location, with differences between rural and urban residents and differences between 
states. The concept of ‘availability’ means that health care demands are covered by the 
health care provider, including operation and travel times and to ensure sufficient staff 
and equipment in health facilities to meet the health demands of a person seeking health 
care. Financial accessibility consists of two elements: the cost of the services and the 
user’s resources and willingness to pay for these services that are in direct relation to 
the health care and socioeconomic status of the user. These factors are the individual’s 
characteristics (including age, sex, and risk factors for the development of diabetes 
complications: diabetes duration, comorbidities, smoking, diabetes treatment) and 
policies at ‘macroenvironmental level’(Peters et al., 2008). The three main columns in 
the conceptual framework (geographic accessibility, availability and financial 
accessibility) are considered to interact with health policies and with the individual’s 
characteristics. The result defines the probability and opportunity for patients with 
diabetes to seek on-going medical care, which influences the development and presence 
of diabetes complications. 
 
Figure 3. Conceptual framework 
 
* Conceptual framework adapted from Peters et al. (2008)(Peters et al., 2008)  
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2.3 Objectives of the quantitative analysis 
 
The aim of this analysis is to assess factors that are associated with presence of 
microvascular diabetes complications in different environmental settings. According to 
prior findings, we assumed that Mexico’s geographically, politically and 
socioeconomically heterogeneous landscape has influenced people’s access to and 
utilisation of preventive diabetes complication screenings, consequently affecting the 
development of diabetes complications. 
Therefore, we analysed whether Mexican people with microvascular complications 
were clustered in certain areas. Using data-mapping techniques, we explored whether 
the geographical pattern of diabetes complications visually matched the distribution of 
areas with lower developmental statuses. We also explored whether a type of health 
care (public health care or no health care versus social health care) and other 
socioeconomic factors at the individual level were associated with the clustering of 
diabetes complications. 
The next step was to analyse whether adherence to follow-up screenings across people 
with diabetes complications depended on their areas of residency (urban or rural), type 
of health care and socioeconomic factors. Descriptive statistics and logistic regression 
analysis were used, with performance of follow-up screenings and the number of 
consultations over the past 12 months as independent variables.  
Spatial patterns of diabetes mortality and burden have been previously described. 
However, to our knowledge, this dissertation’s investigation into the spatial disparities 
of microvascular diabetes complications across Mexico’s states and rural areas is 
unique and aims to support further interventions in less developed areas of Mexico.  
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2.4 Material and Methods 
2.4.1 The National Health and Nutrition Survey (ENSANUT 2012) 
The data for this study were obtained from the National Health and Nutrition Survey 
(Encuesta Nacional de Salud y Nutrición, Ensanut 2012), a probabilistic, multistage and 
clustered household survey representative of the entire Mexican population 
(approximately 115 million inhabitants in 2012), according to estimates by the 
population register in 2012. For each federal state, urban and rural area distributions 
were sampled in proportion to their real size, while areas with the highest deprivation 
were oversampled in order to achieve a considerable sample size even for minorities 
living in these areas. Whether an area was highly deprived or not was decided based on 
an index that was created in 2005 by the Consejo Nacional de Evaluación de la Politica 
de Desarollo Social (CONEVAL). The application of weighting factors for 
oversampled areas were considered to achieve the appropriate weight and ensure 
correct observations. More information on the survey design can be found 
elsewhere(Romero-Martínez et al., 2013). Information on the socio-demographic and 
health-related factors of all participants was obtained. Respondents with a previous self-
reported diagnosis of diabetes were asked further questions regarding diabetes 
complications, duration, care, treatment, among other things. The presence of diabetes 
complications was assessed based on questions asked to individuals about the presence 
of leg or foot ulcers, limb amputation, visual impairment, retinal damage, loss of sight, 
ESRD requiring dialysis and foot pain or burning indicating DN. Blood samples were 
drawn from 751 individuals. However, after exclusion of patients with missing 
information, only 712 of those with HbA1c measurements remained. Participants were 
instructed to fast for 12 hours, and the time of the last meal was registered. No 
distinction between type 1 and type 2 diabetes mellitus was made.  
The datasets containing information on the survey participants were split into several 
datasets. Dataset merging to attain all outcome variables in one dataset was achieved 
using the two key variables, ‘folio’ and ‘intp’, which assign a number to each household 
and to each inhabitant. Depending on the survey group, each dataset contained different 
weighting factors. In this statistical analysis, the weighting factor ‘pondef’ (≥ 20 years 
old) was used for adults. 
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The socioeconomic indicator used in the ENSANUT 2012 was based on the National 
Income and Expenditure Survey conducted in 2010 (INEGI 2010). Briefly, cut-off-
values for each decile were set up2, which assigned each household depending on its 
highest probability to one of the deciles. Variables used for the prediction of the income 
decile were demographic structure of the household, such as years of education, 
employment and sex of the head of family; sociodemographic characteristics, like the 
number of people living in the household or number of children; apartment 
characteristics and goods that resemble a certain level of prosperity; patterns of 
consumption and expenses of the household; and characteristics of the region of 
residency. A detailed description of the assessment of the indicator is described 
elsewhere(Gutiérrez, 2013). In this analysis, we used quintiles, hence each two 
neighbouring deciles were grouped into one, resulting in five quintiles.  
2.4.2 Access to ENSANUT data 
Access to data was permitted by online registration at 
http://ensanut.insp.mx/forma_registro.php#.Vg2LQXi4k0o. The name and email 
address of the submitter, name of a responsible person, institution, investigator’s role 
and a brief description of the investigator’s topic was requested for the registration. 
Once registration was completed, access to data download was permitted with a 
username and password.   
                                               
2 Income decile: ‘The total income deciles divide the population aged 15 years and over into 10 equal-
sized groups according to the rank of the total income. Those in the bottom decile group are the ones who 
fall in the lower 10 percent of the total income distribution. Those in the top decile group are the ones 
who fall in the highest ten percent of the total income distribution’ (Statistics Canada, 2016). 
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2.4.3 Statistical Methods 
Figure 4 outlines the analytical procedure of this analysis. In summary, this analysis 
was divided into three main chapters, exploring differences among individuals, states 
and rural/urban areas.  
At first, individuals with and without diabetes complications were described using 
univariate analysis. We included variables that were positively associated with the 
presence of diabetes complications in previous publications. Variables that were 
significantly associated with the presence of diabetes complications in the univariate 
analysis or variables of particular interest were subsequently used as covariates in the 
logistic regression analysis.  
Second, a descriptive analysis was performed to explore the prevalence of diabetes 
complications across the 32 federal states of Mexico. States with high, intermediate and 
low rates of diabetes complications were grouped, and univariate analysis was 
performed in accordance with the results of the logistic regression in order to explore 
socioeconomic differences among the states with different complication rates.  
Lastly, a descriptive and multivariate logistic regression analysis explored differences 
between residents with diabetes complications from rural and urban areas with regard to 
guideline adherence of preventive measures.  
To estimate the distribution of the groups that we compared, we calculated percentages 
for categorical variables and measures of central tendency for numerical variables. The 
Rao-Scott chi-square test as an adjusted version of the Pearson chi-square test was used 
to estimate univariate associations(Rao & Scott, 1987). A significance threshold was set 
at .05, and p-values were provided for the descriptive analysis. All calculations were 
performed using the Complex Sample Function of SPSS 22.0. A comprehensive guide 
for statistical analysis of the ENSANUT data can be found elsewhere(Romero 
Martínez, 2012). For the univariate analysis, we provided the weighted and un-weighted 
counts of each subgroup to provide information on the actual number of surveyed 
people and the corresponding people represented. In the logistic regression analysis and 
in the subgroup analysis with small case samples, we preferred to report the actual 
number of surveyed people in order to provide a better idea of the statistical relevance 
and ability to generalise the results for the Mexican population. However, the 
percentages refer to the weighted population, meaning that the counts presented cannot 
be used to calculate the presented proportions.  
 51 
Results of the logistic regression models were presented with estimated Odds Ratios 
(OR) and corresponding 95% confidence intervals. Bonferroni correction was 
considered to reduce the likelihood of finding an erroneous significant effect caused by 
multiple testing. To detect extensive multicollinearity among variables, we calculated 
variance inflation factors (VIF) for each variable. A variance inflation factor greater 
than 10 indicated multicollinearity and such variables were not included to our model, 
as suggested by prior studies (Vatcheva, Lee, McCormick, & Rahbar, 2016).  
 
Figure 4. Analytical procedure 
  
I. Exploratory analysis of factors for presence of diabetes complications 
 
Descriptive analysis of the study sample  
(Individuals with versus individuals without diabetes complications) 
and  
Multivariate logistic regression analysis to identify independent factors of the 
presence of diabetes complications  
II. Prevalence of diabetic complications – Interstate disparities 
 
Exploration of spatial patterns of diabetes and diabetes complications and associated 
risk factors among Mexico’s 32 states 
III. Diabetes care in urban and rural areas  
 
Descriptive analysis of people with diabetes complications in rural and urban areas  
and  
Multivariate logistic regression analysis on preventive measures performed in urban 
versus rural areas among people with diabetes complications 
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I. Exploratory data analysis of factors contributing to the presence of 
diabetes complications 
In order to explore the influence of demographic and socioeconomic factors as well as 
the influence of access to health care on the presence of diabetes complications, we 
used contingency tables and OR to measure the association between the two variables. 
Further logistic regression analyses served to identify independent factors of the 
presence of diabetes complications. In order to avoid multicollinearity in the logistic 
regression analysis, we did not include each preventive item. Instead, we selected ‘any 
preventive measure’ and ‘frequency of diabetes control in the past 12 months’ for the 
logistic regression model. ‘Any preventive measure’ was computed through a simple 
inversion of the values of ‘no preventive measure performed in the past 12 months’. 
Other variables that were not significantly associated with diabetes complications in the 
univariate analysis but were still included in the logistic regression model were 
ethnicity and insurance status, as these variables were of special interest for the 
subsequent analysis. The model included the following variables (* marks the reference 
category):  
 
Dependant variable 
Presence of diabetes complications versus no presence of diabetes complications*.  
 
Independent factors 
Gender Female versus male gender* 
Ethnicity Indigenous versus non-indigenous origin* 
Education Less than primary school, less than secondary school versus 
secondary school or more* 
Employment Unemployed, retiree, housekeeper and ‘other’ versus being 
employed* 
SES Belonging to the 1st, 2nd 3rd, 4th versus 5th quintile* 
Marginality Index High marginality versus low marginality index* 
Antidiabetic 
treatment 
Insulin or oral antidiabetic medication (e.g. Metformin) or the 
combination of both versus no pharmaceutical diabetes treatment* 
Use of alternative 
medicine 
Using alternative medicine (e.g. herbs or traditional healing 
methods) alone versus non-utilisation of alternative medicine* 
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Physical exercise Performance of physical exercise to prevent or delay diabetes 
progression versus no exercising* 
Preventive actions 
performed 
Any preventive measure performed in the past 12 months versus 
no preventive measure performed* 
Annual diabetes 
controls 
Less than four diabetes controls performed by a physician versus 
four or more diabetes controls* 
 
Potential confounders for presence of diabetes complications were used as 
covariates:  
Diabetes duration Respondents were asked how long ago they were first diagnosed 
with diabetes, measured in years with five-year steps 
Age Age of the respondent was measured in years with 10-year steps 
 
 
II. Geographical disparities of diabetes complications across Mexico’s 
states 
Contingency tables were used to calculate the rates of diabetes complications for each 
federal state. States were combined into three groups, with approximately equal 
distributions, of low, intermediate and high rates of diabetes complications. States were 
grouped as follows: 
1) States with low diabetes complication rates (LCR: ≤ 55.0% of people with diabetes) 
2) States with intermediate diabetes complication rates (ICR: 55.1% - 65.0%) 
3) States with high diabetes complication rates (HCR: ≥65.0%) 
The assumption of normality was based on each combination of age, gender and state of 
HCR, LCR and ICR as assessed by visual inspection of Normal Q-Q Plots and 
Histograms for each group and combination of age and sex. Previous results from the 
logistic regression (factors that contributed to the presence of diabetes complication) 
were used to determine whether individual characteristics, socioeconomic factors and 
access to diabetes care differed among the three groups. Again, contingency tables and 
tests for equal cell distributions across the three groups were calculated. 
We further inspected and compared the prevalence of diabetes and diabetes 
complications using choropleth maps. A low prevalence of diabetes served as a 
potential predictor of undiagnosed diabetes across areas with high complication rates 
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similar to previous studies(Zhou et al., 2015). For this reason, we used Tableau Desktop 
Professional 10.3 and created choropleth maps of the prevalence of diabetes and 
diabetes complications. We further inspected geographical patterns of rural residency, 
health insurance status and preventive care utilisation among people with diabetes and 
compared these patterns to the spatial distribution of rates of diabetes complications. 
The outlines of the maps were downloaded from the ‘ArcGIS’ homepage: 
http://www.arcgis.com/home/item.html?id=ac9041c51b5c49c683fbfec61dc03ba8, (last 
accessed 02-02-2018). The shapefile was provided by mhoel@uss.on.ca, with no 
special restrictions or limitations on using and publishing the outline of the map. 
 
Data Visualization using Tableau Desktop Software.  
Data Visualization was executed using Tableau 2017 Professional edition, Tableau 
Software Inc., Seattle Washington, United States. Prior registration was requested 
during the installation process of the Tableau Desktop Software. Tableau Desktop is an 
open-source service that allows anyone to publish interactive visualisations of data on 
the web. Visualisations can be embedded in webpages and blogs, they can be shared via 
social media or email, and they can be made available for download to other users. 
Tableau Desktop Software does not claim copyrights and ownership of self-compiled 
maps.  
 
III. The rural-urban divide 
We conducted a further analysis to test the association of diabetes care utilisation 
among rural and urban residents with diabetes complications. The model we established 
to explore rural-urban differences in diabetes care was based on the analytical 
framework from Andersen’s ‘Behavioral Model of Health Services Use’ (Babitsch, 
Gohl, & von Lengerke, 2012). Andersen’s Model used need, predisposing and enabling 
factors to explain differences in health care utilisation. The presence of diabetes 
complications, comorbidities and diabetes duration defined the need for diabetes care. 
Predisposing factors include demographic characteristics (age and sex) and social 
factors (occupational status and ethnicity) that ‘biologically’ and ‘culturally’ predispose 
individuals to use health care services. Enabling factors include financial and 
organisational factors, such as the socioeconomic and health insurance status of 
individuals, which affect one’s ability to afford health care (See Figure 5). 
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Figure 5. Conceptional framework for assessing health service use and diabetes 
outcome. 
 
First, the univariate analysis was used to test for demographic and socioeconomic 
differences, modelled after the elaborated conceptual framework. We further analysed 
how many people in rural and urban areas received comprehensive diabetes care with 
annual eye and foot revision, Hba1c and MiA tests (‘Comprehensive diabetes care’). 
This variable was determined based on the sum of all the preventive measures carried 
out over the past 12 months. The values of the variable ranged from a minimum of zero 
simultaneous preventive actions to a maximum of four simultaneous preventive 
measures performed in the past 12 months.  
Separate logistic regressions were performed to test the adjusted association of diabetes 
care between rural and urban areas. The dependent variable in each logistic regression 
model contained one of the recommended screenings/diabetes follow-ups that were 
carried out (eye revision, foot revision, HbA1c-, MiA test, venous blood glucose tests 
and four or more diabetes controls with a physician and report of any/no preventive 
measure). An individual’s area of residency (rural vs. urban) served as an independent 
variable. Variables that were expected to interact with the variable of diabetes care 
utilisation were used as covariates (*marks the reference group):  
  
 56 
Dependant variable 
Performance of one annual eye revision, foot revision, HbA1c test, MiA test, venous 
blood glucose tests and four or more diabetes controls with a physician). 
 
Independent factors 
Rural versus urban residency  
 
Model covariates 
1. Predisposing factors: age, female gender, self-reported indigenous origin and 
employment (0 = ‘unemployed’, 1 = ‘employed’, 2 = ‘retiree’, 3 = 
‘housekeeper’ and 4 = ‘other’) 
2. Enabling factors: ENSANUT generated a socioeconomic indicator using 
demographic and socioeconomic data based on the National Income and 
Expenditure Survey 2010. The indicator divided Mexican households into 
quintiles, with ‘1’ representing the least favourable and ‘5’ representing the 
most favourable living conditions. More information on the indicator can be 
found elsewhere (Gutiérrez, 2013). Health insurance was recoded if the 
respondent had ‘0’ for no health insurance, ‘1’ for ‘Seguro Popular’, a social 
health care provider introduced in 2003 by the government to cover the formerly 
uninsured population, and ‘2’ for all other health care provider (e.g. private or 
institutional health care provider). 
3. Need factors: Respondents were asked how many years ago they were first 
diagnosed with diabetes. Furthermore, the presence of comorbidities was 
computed as a composite variable, coded ‘1’ at presence of cardiovascular 
disease (history of myocardial infarction, angina pectoris or cardiac 
insufficiency), previous diagnosis of arterial hypertension and/or previous 
diagnosis of hypercholesterolemia and ‘0’ if none of the mentioned 
comorbidities were present. 
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2.5 Results 
2.5.1 Data quality 
Out of 46,277 adults (people aged 20 years or older), 4,490 people with a previous 
diagnosis of diabetes (representative for approximately 6.4 Million people) were 
surveyed in ENSANUT 2012. We further excluded cases with missing entries. This 
resulted in a final case count of N=4254, with N=236 excluded cases (see Figure 6). 
The distribution of missing entries by variable is depicted below (see Table 6). 
 
Figure 6. Flowchart of inclusion and exclusion criteria of survey participants 
 
Table 6. Distribution of variables with missing values* 
Variable description Variable No. Valid (N) Valid (%) Missing (N) Missing (%) 
Diabetes duration a302b 4454 99.2% 36 0.8% 
Freq. DM controls a305 4472 99.6% 18 0.4% 
Cholesterol test a601 4432 98.7% 58 1.3% 
Triglyceride test a603 4406 98.1% 84 1.9% 
Chol/Trig screening a1001c 4470 99.5% 20 0.5% 
Smoking freq.  a1303a 4489 100% 1 0.0% 
Health insurance  afilia_1ra 4487 99.9% 3 0.1% 
* no missing values were found for all other variables that are not mentioned  
 
 
 
46.277 adults ≥ 20 years 
4.490 people with diabetes 
mellitus 
4.166 people remained in the 
final dataset 
324 cases with missing 
entries 
41.787 cases without a 
diagnosis of diabetes mellitus 
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Except for age and duration of diabetes, included survey participants did not differ 
significantly from participants that were excluded due to missing entries. The 324 
excluded people were approximately 15 years older (p < 0.001), and had a mean 
diabetes duration of 16 years compared to nine years in the work file (p < 0.001). They 
were less likely to be of indigenous origin (20% vs. 23%), lived in rural areas rather 
than in urban or metropolitan areas (16% vs. 15%), reflected a higher prevalence of 
microvascular diabetes complications by 8% and were more likely to have a lower 
socioeconomic background (see Table 7). 
 
Table 7. Description and comparison of ex- vs. included cases 
   Excluded cases 
(N = 324)  
Included cases  
(N = 4166) 
 
Variable 
description 
Variable 
name 
Value N* % / 
Mean(SE) 
N* % / 
Mean(SE) 
p-value≠ 
Age edad years 324 71(1.3) 4166 56 (0.4) <0.001 
Sex sexo female 198 51.0 2569 56.0 0.371 
  male 126 49.0 1597 44.0 
Ethnicity h215 non-indig. 236 80.6 3117 76.9 0.342 
  indigenous 88 19.4 1049 23.1 
Residency est_urb urban/metr. 221 85.1 3012 76.9 0.592 
  rural 1154 16.3 103 14.9 
SES quintiles 1st 106 24.1 890 18.8 0.101 
  2nd 71 24.3 791 19.1 
  3rd 56 21.8 757 17.9 
  4th 58 18.1 963 24.7 
  5th 33 11.7 765 19.5 
Diabetes 
duration 
a302b years 324 16(1.4)) 4166 9(0.2) <0.001 
Complication 
prevalence 
kom_ges  236 68.7 25 61.4 0.172 
* N(total) =counts refer to the un-weighted number 
≠Significance is based on the adjusted second-order Rao-Scott Chi Square statistic.  
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2.5.2 Diabetes complications – Risk factors 
Descriptive analysis of people with and without diabetes complications 
Representative of approximately 5.9 million Mexicans with diabetes, 4,166 people were 
included in the analysis. This resulted in a prevalence of diabetes of 8.1%. Additionally, 
2.3 million people were diagnosed with diabetes but had no diabetes complications 
(38.6% of all people with diabetes). About 3.6 million people with diabetes reported 
having any of the analysed diabetes complications, resulting in a prevalence of 
complications of 61.4% (N=2546). Vision impairment and DN were reported with the 
highest frequencies compared to all analysed complications. Lower extremity 
amputations and renal replacement therapy were reported with the lowest frequencies.  
Figure 7. Diabetes complication prevalence in % of people with diabetes in Mexico 
 
A detailed description of survey participants with and without diabetes complications is 
displayed in Table 8. On an individual level, the female gender (p=0.018) and 
comorbidities (p=0.001), such as arterial hypertension, cardiovascular disease and 
hypercholesterolemia were positively associated with the self-reported presence of 
diabetes complications. Infrastructure in terms of living in rural and highly marginalised 
areas had a significant effect on the presence of diabetes complications. Eighteen 
percent of the respondents with complications lived in rural areas versus 13% in the 
non-complication group (p<0.001), and 20% versus 16%, respectively, lived in highly 
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Figure 9 shows the proportion of people with diabetes complications among 
people with diabetes in Mexico. According to ENSANUT 2012 data, almost 
half of the population reported any kind of vision impairment, while 13% 
reported diagnosed diabetic retinopathy. Diabetic neuropathy was highly 
prevalent as well with a prevalence rate of 38% of the diabetic population. 
More advanced complications such as blindness, diabetic foot/eg ulcer, and 
dialysis were less prevalent.  
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marginalised areas (p=0.009). Similar to this observation, respondents with 
complications were more likely to have a lower socioeconomic background (40% in the 
complication-group belonged to the lowest two lowest socioeconomic quintiles vs. 34% 
in the non-complication group) and more likely to have a higher school degree; 13% of 
the respondents with complications versus 9% in the non-complication group had not 
obtained more than a primary school degree. Correspondingly, unemployment rates 
were higher for those with complications (12% vs. 8%). With regard to the utilisation of 
preventive diabetes care among people with and without diabetes complications, 70% 
of those with complications reported to be seen by a doctor for diabetes control 
purposes. Specific care, such as eye or foot revision, HbA1c tests and tests to check for 
MiA were realised in 7% to 17% of all patients with complications in the previous year 
and was higher among individuals with diabetes complications. Adequate blood glucose 
control with HbA1c levels equal or below 7% was achieved by a minority in both 
groups and was lower in the complication group (22% versus. 24%, respectively). 
However, the difference between both groups was not statistically significant 
(p=0.668). 
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Table 8. Description of participants with and without diabetes complications 
    Respondents without diabetes Respondents with diabetes 
complications 
  
complications 
Variable Value N (weighted 
in 10.000) = 
227.3 
N (raw) = 
1620 
% / 
Mean 
(SE) 
N (weighted 
in 10.000) = 
361.5 
N (raw) = 
2546 
% / Mean 
(SE) 
p-Value 
≠ 
Individual level                
Gender Female  124.7 1017 50.8 2.32 1750 58.6 0.018 
Age, yrs   227.3 1620 54 (0.6) 361.4 2546 57 (0.4) n.a. 
Ethnicity Indigenous origin 55.1 432 22.6 91.1 705 22.9 0.987 
Diabetes duration, yrs   227.3 1620 7 (0.3) 361.4 2546 10 (0.3) n.a. 
Smoking  yes 80.8 534 35.5 137.5 883 38.0 0.335 
 Comorbidities 
 
129.6 885 57.0 237.2 1663 65.6 0.001 
Health care access        
Insurance Uninsured 34.1 225 15.0 60.9 313 16.9 0.176 
  Public  65.7 577 28.9 11.6 988 32.0 
  Other 12.7 818 56.1 18.5 1245 51.2 
Infrastructure rural residency 30.6 438 12.6 72.8 819 18.3 <0.001 
  high marginalization 36.1 490 15.9 72.1 857 19.9 0.011 
Socioeconomic factors        
Socio-economic household 1st quintile 39.6 332 17.4 70.8 558 19.6 <0.001 
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level 2nd quintile 38.6 287 17.0 73.9 504 20.4 
3rd quintile 36.3 273 16.0 69.0 484 19.1 
4th quintile 54.2 368 23.8 91.3 595 25.3 
  5th quintile 58.5 360 25.8 56.3 405 15.6 
Education none/less than 
primary 
21.34 211 9.4 48.5 368 13.4 <0.001 
  less than secondary 147.2 1094 64.8 267.6 1892 74.0 
  secondary or more 5.9 315 25.8 45.3 286 12.5 
Employment unemployed 12.2 73 5.4 27.7 191 7.7 0.001 
  employed 114.5 719 49.9 136.0 906 37.6 
  retiree 21.8 146 9.6 34.7 237 9.6 
  housekeeper 70.3 624 30.9 148.5 1127 41.1 
 
other 9.5 58 4.2 14.4 85 4.0 
Diabetes care/Treatment adherence        
Treatment Insulin and/or oral 
agent 
177.5 1322 78.1 326 2322 90.2  
  Nothing 49.8 298 21.9 35.4 224 9.8 <0.001 
  Alternative medicine 14.4 125 6.3 43.4 271 12.0 <0.001 
Prevention ≥ 4 doctor visits 126.9 1025 55.8 252.2 1860 69.8 <0.001 
  HbA1c controls 19.4 119 8.5 35.33 244 9.7 0.420 
 Venous blood 
glucose control 
104.7 708 46.1 208.0 1392 57.6 <0.001 
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  Foot revision 22.8 157 10.0 60.0 385 16.6 <0.001 
  Eye revision 15.7 121 6.9 34.8 236 9.6 0.041 
  Microalbuminuria 
test 
14.9 90 6.6 35.8 218 9.9 0.064 
  No prevention 159.7 1196 70.3 223.2 1670 61.7 0.001 
Glycaemic control HbA1c ≤ 7% 7.7 58 23.9 12.8 91 21.6 0.668 
 HbA1c > 7% 24-4 187 76.1 46.6 365 78.4  
People with diabetes: N (total)= 4166  
All calculations (%/SE) refer to the weighted counts (N weighted) and cannot be calculated using N(raw) 
1N(glycemic control, un-weighted) = 701 
≠p- Values were calculated using adjusted Rao-Scott Pearson Chi- Square statisticS.  
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Logistic regression analysis of contributing factors to the presence of diabetes 
complications 
We analysed the association between the presence of diabetes complications and 
demographic, socioeconomic and diabetes-related factors using logistic regression 
analysis, with the presence of diabetes complications as the outcome/dependent 
variable. Results are presented in Table 9. Individuals with diabetes complications were 
more likely to have less than secondary or primary school education (OR = 1.46; 
p=0.004) and were more likely to live in rural areas (OR = 1.31; p=0.034). The 
socioeconomic household level of Mexicans with diabetes was significantly associated 
with the presence of diabetes complications; compared to the 5th quintile, residents from 
lower quintiles were approximately 1.5 times more likely to present diabetes 
complications, except for the lowest quintile, which missed the significance threshold. 
Similarly, adults enrolled in ‘Seguro Popular’ did not have significantly higher odds of 
reporting a previous diagnosis of one of the complications. However, those without 
health insurance, compared to people that were affiliated with institutional health care, 
were 1.6 times more likely to have diabetes complications (p=0.01). In terms of 
antidiabetic treatment, one’s likelihood of presenting diabetes complications and using 
alternative medicine was twofold compared to respondents who did not use alternative 
medicine (homeopathy, herbal medicine and other alternative medicine). Ongoing 
treatment with insulin and/or oral antidiabetic agents increased a person’s OR of 
reporting diabetes complications by 1.81 times compared to respondents with no 
pharmaceutical treatment (95%CI = 1.27 – 1.59). People who exercised regularly were 
more likely to belong to the non-complication group (OR = 0.62; 95%CI = 0.45 – 0.82). 
Prevention was significantly more common among those with diabetes complications. 
Any preventive screening and more than four annual diabetes controls were more likely 
provided to people with complications (OR = 1.56; 95%CI = 1.22 – 1.99). However, 
more than four annual diabetes controls missed the significant level with borderline 95-
CI intervals (OR = 1.30; 95%CI = 0,99 - 1.69), but was greater among people with 
diabetes complications. Diabetes duration increased the likelihood of having diabetes 
complications by 1.18 for every five years, but age did not increase the risk of 
experiencing diabetes complications significantly. 
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Table 9. Multivariate logistic regression analysis of independent factors predicting the 
presence of diabetes complications 
Variables OR 95% CI 
  Lower Upper 
Age  1.01 0.89 1.13 
Female gender 0.96 0.71 1.29 
Ethnicity    
Indigenous origin  0.96 0.73 1.20 
Non-indigenous origin . . . 
Education    
Less than primary school 1.46 1.00 2.15 
Less than secondary 
school 
1.48 1.16 1.90 
Secondary school or 
more 
. . . 
Employment    
Unemployed 1.39 0.75 2.59 
Retiree 1.06 0.68 1.66 
Housekeeper 1.31 0.96 1.79 
Other 0.98 0.51 1.88 
Employed . . . 
Socioeconomic level    
1st quintile 1.32 0.93 1.88 
2nd quintile 1.48 1.04 2.11 
3rd quintile 1.59 1.11 2.28 
4th quintile 1.50 1.06 2.12 
5th quintile . . . 
Marginality Index    
High 1.09 0.87 1.37 
Low . . . 
Residency    
Rural  1.31 1.02 1.69 
Urban/Metropolitan . . . 
Health insurance    
None 1.62 1.15 2.27 
Seguro popular 1.10 0.83 1.46 
Else . . . 
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Antidiabetic treatment 
Insulin and/or oral agent 1.81 1.27 2.59 
None . . . 
Use of alternative 
medicine 
   
Yes 2.03 1.42 2.88 
No . . . 
Physical exercise    
Yes 0.62 0.45 0.82 
No . . . 
Diabetes duration (per 5 
years) 
1.18 1.08 1.29 
Presence of 
comorbidities 
   
Yes 1.42 1.15 1.75 
No . . . 
Preventive actions 
performed 
   
Yes 1.56 1.22 1.99 
No . . . 
 Annual diabetes 
controls 
   
< 4 0.77 0.59 1.01 
≥ 4 . . . 
Population sample: Mexican residents with a previous diagnosis of diabetes (N 
= 4166) 
* Pseudo R2 Nagelkerke: 0.144 
** Reference category: individuals without diabetes complication 
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2.5.3 Regional disparities with regard to the presence of diabetes 
complications 
The geographic pattern of rates of diabetes and diabetes complications differed 
across Mexico’s federal states. Diabetes prevalence ranged from 5.3% in Chiapas 
to 11.3% in Mexico City, resulting in a mean of 8.5%. Prevalence of any 
microvascular diabetes complications as a percentage of the population with 
diabetes varied from 42% in Quintana Roo to 77% in Guanajuato and Tamaulipas, 
resulting in a mean of 61.4%. Figure 8 and Figure 9 display the heterogeneous 
distribution of diabetes and its complications. Diabetes prevalence was highest 
along the Gulf of Mexico, in the state of Mexico and in Mexico City and was 
lowest in the southwest and parts of northern Mexico (Figure 8). Increased diabetes 
complication rates were observed mostly in states located in the centre and east 
central part of Mexico (Figure 9). The state with the strongest discrepancy, 
demonstrating a low prevalence of diabetes and a high prevalence of diabetes 
complications, was Chiapas. Chiapas had the lowest prevalence of diabetes of the 
32 states (5.3%), but ranked 24th of 32 states in regard to the prevalence of diabetes 
complications (approximately 68%). Michoacán and Guanajuato followed this 
trend with rates of diabetes of 7.1% and 7.6%, respectively,, and a diabetes 
complication rate of 73% and 77%, respectively.  
Three groups of states were established in accordance with their respective diabetes 
complication rates. States with HCR (≥ 65.0% of the population with diabetes) 
included Chiapas (67.9%), Tlaxcala (68.4%), Durango (68.9%), Jalisco (68.9%), 
Chihuahua (70.0%), Michoacán (71.8%), Veracruz (72.2%), San Luis Potosi (74.7%), 
Tamaulipas (76.5%) and Guanajuato (76.5%). 
States with ICR (55.0% - <65.0%) were Colima (57.3%), Tabasco (58.5%), Federal 
District (=Mexico City) (58.7%), Aguascalientes (58.9%), Queretaro (60.8%), 
Zacatecas (62.5%), Puebla (63.6%), Nuevo León (63.2%), Coahuila (64.0%), and 
Oaxaca (63.1%).  
The lowest complication rates (LCR < 55.0%) were observed in Quintana Roo 
(41.7%), Baja California North (44.5%), Yucatán (45.2%), Nayarit (45.5%), Sonora 
(46.0%), Sinaloa (48.7%), Morelos (49.8%), Baja California South (50.4%), 
Campeche (51.4%), Guerrero (53.6%), Mexico (53.9%) and Hidalgo (54.4). 
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Figure 8. Distribution of diabetes prevalence in Mexican states, in % of the general 
population 
  
  
Figure 8 shows the rate of people that reported a previous diabetes diagnosis across all citizens from 
the 32 Mexican states. Chihuahua and the southern coast as well as states bordering with Central 
America in the south show low rates beginning from 5.6% in Chiapas. In some states along the gulf of 
Mexico as well as in Baja California Norte we observed more than twice as many people with diabetes 
compared to the north of Mexico and the south- and west coast of Mexico.   
 
Abbreviations of states: AGUA = Aguascalientes, BCN = Baja California North, BCS = Baja California 
South, CAMP = Campeche, CHIA = Chiapas, CHIH = Chihuahua, COAH = Coahuila, COLI = Colima, DF = 
Federal district, DURA = Durango, GUANA = Guanajuato, GUERR = Guerrero, HIDA = Hidalgo, JALI = 
Jalisco, MEXI = Mexico, MICH = Michoacán, MORE = Morelos, NAYA = Nayarit, NULE = Nuevo León, 
OAXA = Oaxaca, PUEB = Puebla, QUER = Queretaro, QURO = Quintana Roo, SLP = San Luis Potosi, 
SINA = Sinaloa, SONO = Sonora, TABAS = Tabasco, TAMAU= Tamaulipas, TLAX= Tlaxcala, VERA= 
Veracruz, YUCA = Yucatán, Zaca = Zacatecas 
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Figure 9 shows the rate and distribution of people with diabetes complications across all 
people with diabetes and across all states. The highest rate of complications by state was 
found in Guanajuato with 76.5%. States with a high rate of diabetes complications (≥ 65% of 
all people with diabetes) included: Chiapas (67.9%), Tlaxcala (68.4%), Durango (68.9%), 
Jalisco (68.9%), Chihuahua (70.0%), Michoacán (71.8%), Veracruz (72.2%), San Luis 
Potosi (74.7%), Tamaulipas (76.5%). The lowest rates were found in the northwest in Sonora 
Baja California, Nayarit, Sinaloa and on the Yucatan Peninsula starting at 41.7%.  
 
Abbreviations of states : AGUA = Aguascalientes, BCN = Baja California North, BCS = Baja 
California South, CAMP = Campeche, CHIA = Chiapas, CHIH = Chihuahua, COAH = Coahuila, 
COLI = Colima, DF = Federal district, DURA = Durango, GUANA = Guanajuato, GUERR = 
Guerrero, HIDA = Hidalgo, JALI = Jalisco, MEXI = Mexico, MICH = Michoacán, MORE = Morelos, 
NAYA = Nayarit, NULE = Nuevo León, OAXA = Oaxaca, PUEB = Puebla, QUER = Queretaro, 
QURO = Quintana Roo, SLP = San Luis Potosi, SINA = Sinaloa, SONO = Sonora, TABAS = 
Tabasco, TAMAU= Tamaulipas, TLAX= Tlaxcala, VERA= Veracruz, YUCA = Yucatán, Zaca = 
Figure 9. Diabetes complications in % of people with diabetes 
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For further comparison across the three groups, we checked the assumption of 
normality, which was satisfied for age and all group combinations of gender and 
classification as a state with high, intermediate and low complications. Furthermore, 
we used contingency tables to analyse the relationship between socioeconomic levels, 
health care status, rural residency and received diabetes care for those living in areas 
with high rates of diabetes complications versus those in states with lower 
complication rates. Results are presented in Table 10. Only ethnicity, indigenous 
versus non-indigenous origin, was not significantly associated with residency in HCR 
states. Comparison of the socioeconomic statuses between HCR and LCR/ICR states 
revealed that HCR states had a higher number of households belonging to lower 
quintiles (1st and 2nd) compared to ICR/LCR states (HCR=43.0% vs. 35.2%, p=0.033) 
according to ENSANUT data.  
In terms of rural residency, there was a large difference between the groups: 
approximately 23% of people with diabetes living in HCR states came from rural 
areas compared to 13% in ICR and LCR states (p ≤ 0.001). A significant difference 
with regard to the type of health insurance was observable. A majority of those in the 
ICR/LCR group received tax-funded institutional health care (55.0%), whereas 
individuals from states with a prevalence of high complications were rather affiliated 
with ‘Seguro Popular’ or had no health insurance (50.8%), (p= 0.033).  
 
There were significant differences with regard to the utilisation of preventive 
measures across the three groups. Less people in HCR states performed any 
preventive measures (p=0,004) and received annual HbA1c tests (p<0.004). However, 
higher rates of frequent physician visits for diabetes care (≤4 annual visits) and 
determination of venous blood glucose were reported among residents from HCR 
states. No significant difference was observed with regard to eye revisions and 
screenings for MiA (see Table 10). 
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Table 10. Descriptive analysis of individuals with diabetes living in states with a high 
prevalence of diabetes complications 
 
HCR* 
N (raw = 2941) 
LCR/ICR* 
N (raw = 1320) 
p-Value≠ 
Socioeconomic quintile 
  
0.033 
1st (lowest) 20,6% 17,8% 
 
2nd 22.4% 17.4% 
 
3rd 16.6% 18.5% 
 
4th 22.2% 26.0% 
 
5th (highest) 18.1% 20.2% 
 
Ethnicity 
  
0.288 
indigenous 21.5% 24.0% 
 
non-indigenous 78.5% 76.0% 
 
Health insurance 
  
0.033 
None 15.7% 16.3% 
 
Public health care 35.1% 28.6% 
 
Institutional/Private health care 49.2% 55.0% 
 
Any preventive measure 
 
0.004 
yes 29.3 37.6% 
 
no 70.3% 62.4% 
 
Frequency of physician visits   0.030 
≥ 4 68.1% 62.5%  
<4 31.9% 37.5%  
Residency 
  
<0.001 
rural 22.5% 13.1% 
 
urban/metropolitan 77.5% 86.9%  
 
*HCR = high complication rate; states with a diabetes complication prevalence ≥ 
65.0%, LCR/ICR = low/intermediate complication rates; states with a diabetes 
complication prevalence <65.0% 
≠p-values were calculated using Rao-Scott adjusted Chi-Square statistics  
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Figure 10. Use of preventive diabetes care among states with low-intermediate and 
high rates of diabetes complications 
 
Spatial distribution of individuals by health insurance status, rural residency and 
utilisation of diabetes care  
Across people with diabetes, frequencies of public health care (‘Seguro Popular, SP’) 
or lack of health insurance were higher in southern states and lower in the centre and 
the north. Affiliation with public health care among people with diabetes ranged from 
8.7% in Coahuila in the north to 57.4% in Chiapas in the south. Lack of health 
insurance was lowest in Aguascalientes (Central Mexico) at 3.4% and highest in 
southern states in Guerrero and Michoacán (27.0% and 26.6%, respectively). In 
Figure 12 we mapped the distribution of people that are either uninsured or receiving 
public health care and observed increasing rates from the north to the south. The 
distribution of uninsured/SP affiliates matched the development pattern of states 
(using Mexico’s rankings on the Human Development Index with data provided by 
development data reports of the UN) as displayed in Figure 11. Chiapas, Guerrero, 
Oaxaca and Michoacán had the lowest ranking on the Human Development Index 
(0.667 – 0.700) and reflected high frequencies of non-utilisation of preventive 
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Figure 9 shows thata any preventive measure was performed by only 30% and 38% of people in
LCR/ICR and HCR states, respectively.
Specific preventive measures (HbA1c, foot revision, microalbuminuria test) were performed more
often in states with low/intermediate complication rates.
Conversely, frequent physician visits and venous blood glucse tests were performed more often in
states with high complication rates (≥65% with diabetes complications = HCR states).
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measures (72.6% in Michoacán to 82.3% in Guerrero). The highest rates of non-
utilisation were observed in Quintana Roo, Guerrero and Chihuahua, with more than 
80% of people reporting that no preventive measure had been taken in the past year, 
compared to approximately 50% non-utilisation in Queretaro and Mexico City 
(Figure 13). Furthermore, the proportion of people with diabetes living in rural areas 
was high among states with low developmental profiles and lack of health insurance 
or SP affiliation (28.2% in Chiapas, 26.1% in Guerrero, 28.0% in Oaxaca and 29.2% 
in Michoacán), compared to the average of 15.9%. However, the states with largest 
rural areas were located in the centre (Zacatecas = 46.8% and Hidalgo= 41.1%) and 
to the south (Tabasco = 36.8% and Veracruz = 33.9%) (Figure 14). 
The spatial distribution of rates of diabetes complications visually matched neither 
the pattern of health insurance and development status nor the rates of non-utilisation 
of preventive measures despite statistical associations in the logistic regression 
analysis.  
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State abbreviations for Fig 11 and 12: AGUA = Aguascalientes, BCN = Baja California North, BCS = Baja 
California South, CAMP = Campeche, CHIA = Chiapas, CHIH = Chihuahua, COAH = Coahuila, COLI = Colima, 
DF = Federal district, DURA = Durango, GUANA = Guanajuato, GUERR = Guerrero, HIDA = Hidalgo, JALI = 
Jalisco, MEXI = Mexico, MICH = Michoacán, MORE = Morelos, NAYA = Nayarit, NULE = Nuevo León, 
OAXA = Oaxaca, PUEB = Puebla, QUER = Queretaro, QURO = Quintana Roo, SLP = San Luis Potosi, SINA = 
Sinaloa, SONO = Sonora, TABAS = Tabasco, TAMAU= Tamaulipas, TLAX= Tlaxcala, VERA= Veracruz, 
YUCA = Yucatán, Zaca = Zacatecas 
§HDI data were retrieved from the Human Development Data Reports established by the UN; the score consider 
three dimensions: the life expectancy index, Education index and GNI index and explains how two countries or 
states with similar GNI per capita score different human development index (De la Torre García, 2015).   
Fig .11 shows the HDI for 
each state in Mexico. From 
north to south the HDI shows 
a decreasing trend according 
to data from the United Nation 
Development Program§. It is 
highest in Nuevo Leon  
(north-east) with 0.83, 
equivalent to the HDI of 
developed countries 
(HDI>0.732), and lowest in 
Chiapas, Oaxaca and Guerrero 
with 0.667 (equivalent to the 
HDI of developing countries).  
Figure 11. Human development index by state, general population in Mexico* 
Figure 12. Rates of individuals with public health care (Seguro Popular) or no health 
insurance, in % of people with diabetes*§ 
Fig. 12. Analogue to Fig. 
11 an increase from the 
north to the south can be 
observed considering  
the health care status 
among people with 
diabetes. More people 
with diabetes that were 
formerly uninsured and 
are insured with public 
health care or remain 
uninsured can live in 
southern Mexico and on 
the Yucatán.  
Peninsula. 
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Figure 14. Rates of rural residency, % of people with diabetes*  
 
 
 
*State abbreviations for Fig 13 and 14: AGUA = Aguascalientes, BCN = Baja California North, BCS = Baja 
California South, CAMP = Campeche, CHIA = Chiapas, CHIH = Chihuahua, COAH = Coahuila, COLI = Colima, 
DF = Federal district, DURA = Durango, GUANA = Guanajuato, GUERR = Guerrero, HIDA = Hidalgo, JALI = 
Jalisco, MEXI = Mexico, MICH = Michoacán, MORE = Morelos, NAYA = Nayarit, NULE = Nuevo León, 
OAXA = Oaxaca, PUEB = Puebla, QUER = Queretaro, QURO = Quintana Roo, SLP = San Luis Potosi, SINA = 
Sinaloa, SONO = Sonora, TABAS = Tabasco, TAMAU= Tamaulipas, TLAX= Tlaxcala, VERA= Veracruz, 
YUCA = Yucatán, Zaca = Zacatecas 
  
Figure 12 shows the non-
utilisation of preventive 
measures across the 
population with diabetes, 
except for Chihuahua 
southern states and 
Yucatán have lower 
proportions for diabetes 
care participation 
compared to southern 
states except for 
Chihuahua 
Figure 13 demonstrates 
the proportion of people 
with diabetes living in 
rural areas. Comparing 
Figure 12 and 13 rural 
residency and non-
utilisation of preventive 
measures matches for 
southern states, Zacatecas 
and Nayarit on visual 
inspection.  
Figure 13. Rates of non-utilisation of preventive measures % of people with diabetes 
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2.5.4 The rural-urban divide of diabetes care and diabetes complications 
Descriptive analysis of people with diabetes complications in rural and urban areas 
of Mexico  
As expected, diabetes rates were higher in urban areas of Mexico (urban: 9.0% versus 
rural: 6.5%), whereas the rate for diabetes complications was higher for rural areas – 
approximately 70% in rural areas and 60% in urban areas. See Figure 15. 3  
From a socioeconomic perspective, a greater part of the rural population with diabetes 
complications belonged to the 1st and 2nd quintiles (34.8% and 23.2%). Additionally, 
21.1% of the rural versus 12.1% of the urban participants did not have any school 
degree. Affiliation with public health care (‘Seguro Popular’) was more common 
among rural residents (rural = 57% vs. urban = 26%), while urban residents preferred 
affiliation with institutional and private health care (rural = 27% vs. urban= 57%). 
Similar distributions for absence of health care coverage were observed in both 
groups (16% in urban areas and 17% in rural areas). In terms of comorbidities and 
cardiovascular risk factors, we observed lower risk profiles for the rural population. 
Hypercholesterolemia and cardiovascular disease were more common among urban 
residents. In addition, in terms of preventive measures, rural residents were 
significantly less likely to have had one annual foot revision (p=0.002), MiA testing 
(p=0.010) and venous blood glucose testing (p=0.017) (see Table 11). 
 
Comprehensive diabetes care  
The number of preventive measures performed in the past 12 months differed 
between the two groups. No prevention measures were reported by 71% of people (n= 
527) in rural areas, compared to 60% (n=1143) in urban areas. This subgroup was 
more likely to have a lower school degree, belong to a lower socioeconomic level, 
was either affiliated to public health care (Seguro Popular) or had no health insurance, 
lived in a rural area and was less likely to report cardiovascular comorbidities (not 
displayed). However, the majority of rural and urban participants stated they had seen 
their physician for regular and frequent (four or more times) diabetes controls in the 
previous 12 months with no difference between the two groups (70% in urban and 
                                               
3 The following description refers to Mexicans with diabetes complications.  
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70% in rural areas).  
Venous blood glucose testing compared to other more specific tests was relatively 
common. Half of the rural population versus approximately 60% of the urban 
population stated that their venous blood glucose was tested in the past 12 months, 
whereas all other screening tests (eye and foot revision, MiA and HbA1c testing) 
were performed less frequently. On average, 7.5% of rural residents and 12.9% of 
urban residents had performed one of these specific screening tests. Less than 10% of 
all respondents reported more than two simultaneous tests in 12 months, and 
approximately 1% of the respondents received more comprehensive diabetes care, 
with all four preventive measurements performed in the past 12 months.  
 
Figure 15. Urban versus rural areas: Diabetes and diabetes complication rates 
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Table 11. Descriptive analysis - diabetes care in rural and urban areas 
  
 
Diabetes care in the  
past 12 months 
Rural residency 
≤ 2500 inhabitants 
N=7431 (29.2%) 
Urban/ 
metropolitan 
residency 
> 2500 inhabitants 
N=1803 (70.8%) 
P-Value2 
Eye revision   
0.006 Yes 48 (5.6) 188 (10.5) 
No 695 (94.4) 1615 (89.5) 
Foot revision    
0.002 Yes  84 (10.8) 301 (17.9) 
No 659 (89.2) 1502 (82.1) 
Microalbuminuria test   
0.074 Yes 50 (6.2) 168 (10.6) 
No 693 (93.8) 1653 (89.4) 
HbA1c monitoring   
0.037 Yes 53 (6.5) 191 (10.5) 
No 690 (93.5) 1612 (89.5) 
Venous blood glucose 
testing 
Yes 
No 
 
 
354(50.0) 
389 (50.0) 
 
 
1038 (59.3) 
765 (40.7) 
0.017 
Physician visit    
0.971 ≥ 4 551 (69.7) 1309 (69.8) 
< 4 192 (30.3) 494 (30.2) 
No preventive action 
0.001 Yes 527 (71.0) 1143 (59.7) 
No 219 (29.0) 660 (40.3) 
1 Counts refer to the un-weighted number of individuals (number of individuals that were actually 
interviewed), percentages refer to the weighted number of individuals representative to Mexico’s 
entire population).  
2 Results and p-value were calculated using Pearson’s Chi Square statistics 
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Logistic regression results for adjusted associations between residency and diabetes 
care utilisation.  
Table 12 summarises the findings of the logistic regression models, displaying the 
association between residency and diabetes care among Mexicans with diabetes 
complications after adjusting for age, sex, ethnicity, employment status, 
socioeconomic level, health insurance status, diabetes duration and comorbidities. No 
prevention was reported significantly more often among individuals living in rural 
areas (OR = 1.39, 95%CI = 1.02-1.90). Rural residency was also associated with 
lower odds of performance of foot examinations (OR= 0.64, 95%CI = 0.42 – 0.97). 
Except for frequency of doctor visits, other preventive methods displayed the same 
trend but did not reach a significant level. Significance was maintained even after 
Bonferroni adjustment. Lower socioeconomic status was significantly associated with 
people that reported non-utilisation of any preventive measures in the past 12 months. 
The first, second and third quintile had approximately two to three times higher OR 
for reporting lack of any performed preventive measures (1st quintile: OR = 2.48; 
95%CI 1.59 – 3.88; 2nd quintile: OR = 2.46; 95%CI = 1.61 – 3.77; 3rd quintile: OR = 
2.10; 95%CI = 1.36 – 3.25 versus 5th quintile). The lowest socioeconomic quintile 
also had significantly lower OR for reporting HbA1c testing in the previous year, 
compared to the highest quintile (OR= 0.40; 95%CI = 0.21 – 0.76). On the other 
hand, lower socioeconomic status was not significantly associated with the reception 
of any other preventive screening. 
In addition, health insurance status was not significantly associated with the 
utilisation of specific diabetes care among people with diabetes complications. 
However, health care provider and frequency of physician visits were significantly 
associated. Respondents with Social Security (IMSS, ISSSTE) were four times more 
likely to reach the recommended standard of four physician visits per year, compared 
to those without health care (OR = 4.35; 95%CI = 2.78 – 6.67). Correspondingly, 
respondents with no health insurance were significantly less likely to receive a venous 
blood glucose test in the past 12 months (OR= 0.44; 95%CI: 0.30 – 0.67) 
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Table 12. Logistic regression results for associations between diabetes care and rural 
versus urban residency among Mexican adults with diabetes complications 
 
No preventive action 
(N=2546) 
HbA1c test 
(N=2546) 
 OR 95% CI OR 95%CI 
Residency 
Rural 
Urban 
 
1.391 
. 
 
(1.02 – 1.90) 
. 
 
0.62 
. 
 
(0.36 – 1.06) 
. 
Age 
≤ 40 
41 – 60 
61 – 80 
> 80 
 
. 
1.23 
1.38 
2.10 
 
. 
(0.78 – 1.94) 
(0.87 – 2.20) 
(0.84 – 5.22) 
 
. 
0.74 
0.73 
0.13 
 
. 
(0.38 – 1.44) 
(0.34 – 1.58) 
(0.03 – 0.53) 
Female gender 0.97 (0.69 – 1.37) 1.63 (0.93 – 2.88) 
Ethnicity 
Indigenous 
Non – indigenous 
 
1.03 
. 
 
(0.76 – 1.41) 
. 
 
0.98 
. 
 
(0.64 – 1.51) 
. 
Socioeconomic level 
1st quintile 
2nd quintile 
3rd quintile 
4th quintile 
5th quintile 
 
2.48 
2.46 
2.10 
1.35 
. 
 
(1.59 – 3.88) 
(1.61 – 3.77) 
(1.36 – 3.25) 
(0.90 – 2.03) 
. 
 
0.40 
0.74 
0.66 
0.64 
. 
 
(0.21 – 0.76) 
(0.40 – 1.38) 
(0.36 – 1.24) 
(0.36 – 1.16) 
. 
Employment 
Unemployed 
Retiree 
Housekeeper 
Employed 
 
1.29 
0.79 
1.03 
. 
 
(0.72 – 2.31) 
(0.49 – 1.28) 
(0.71 – 1.50) 
. 
 
1.79 
1.19 
0.75 
. 
 
(0.73 – 4.34) 
(0.56 – 2.53) 
(0.47 – 1.22) 
. 
Health insurance 
None 
Seguro Popular 
Else 
 
1.40 
1.10 
. 
 
(0.92 – 2.12) 
(0.79 – 1.51) 
. 
 
1.39 
1.30 
. 
 
(0.81 – 2.40) 
(0.83 – 2.04) 
. 
Diabetes duration 
(per 5 years) 0.94 (0.87 – 1.01) 0.95 (0.86 – 1.05) 
Comorbidities 
Yes 
No 
 
0.76 
. 
 
(0.57 – 1.02) 
. 
 
1.26 
. 
 
(0.78 – 2.05) 
. 
 81 
  
 
Continuation Table 12 
 Eye revision 
(N=2546) 
Foot revision 
(N=2546) 
 OR 95% CI OR 95%CI 
Residency 
Rural  
Urban 
 
0.64 
. 
 
(0.39 – 1.04) 
. 
 
0.64 
. 
 
(0.42 – 0.97) 
. 
Age  
≤ 40 
41 – 60 
61 – 80 
> 80 
 
. 
0.77 
0.97 
0.59 
 
. 
(0.41 – 1.44) 
(0.48 – 2.00) 
(0.14 – 2.50) 
 
. 
1.32 
1.15 
0.97 
 
. 
(0.39 – 4.44) 
(0.39 – 3.38) 
(0.34 – 2.81)  
Female gender 1.13 (0.69 – 1.83) 1.51  (0.98 – 2.33) 
Ethnicity 
Indigenous 
Non – indigenous 
 
1.49 
. 
 
(0.91 – 2.46) 
. 
 
0.91 
 
 
(0.62 – 1.35) 
Socioeconomic level 
1st quintile 
2nd quintile 
3rd quintile 
4th quintile  
5th quintile 
 
0.53 
0.53 
0.35 
0.69 
. 
 
(0.27 – 1.05) 
(0.26 – 1.10) 
(0.16 – 0.78) 
(0.35 – 1.36) 
. 
 
0.70 
0.64 
0.53 
0.97 
. 
 
(0.40 – 1.24) 
(0.37 – 1.09) 
(0.30 – 0.95) 
(0.58 – 1.62) 
. 
Employment 
Unemployed 
Retiree  
Housekeeper 
Employed 
 
1.08 
1.25 
0.79 
. 
 
(0.40 – 2.93) 
(0.61 – 2.57) 
(0.45 – 1.39) 
. 
 
1.15  
1.24 
0.81 
. 
 
(0.55 – 2.41) 
(0.68 – 2.26) 
(0.52 – 1.27) 
. 
Health insurance 
None 
Seguro Popular 
Else  
 
0.64 
0.61 
. 
 
(0.27 – 1.51) 
(0.39 – 0.97) 
. 
 
1.07 
0.98 
. 
 
(0.62 – 1.83) 
(0.63 – 1.52) 
. 
Diabetes duration  
(per 5 years) 
1.19 (1.05 – 1.34) 1.15 (1.04 – 1.27) 
Comorbidities 
Yes  
No 
 
1.39 
. 
 
(0.94 – 2.05) 
. 
 
1.14 
. 
 
(0.78 – 1.66) 
. 
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Continuation Table 12.  
 Microalbuminuria test 
 (n = 2546) 
Venous blood glucose test 
 (n = 2546) 
 OR  95% CI OR  95% CI 
Residency 
Rural  
Urban 
 
0.82  
. 
 
(0.47 -1.44) 
. 
 
1.21 
. 
 
0.89 – 1.66 
. 
Age  
≤ 40 
41 – 60 
61 – 80 
> 80 
 
. 
0.59 
0.52 
0.41 
 
. 
(0.31 – 1.13) 
(0.24 – 1.14) 
(0.11 – 1.54) 
 
. 
0.96 
0.77 
0.84 
 
. 
(0.60 – 1.52) 
(0.48 – 1.24) 
(0.29 – 2.48) 
Female gender 1.23 (0.69 – 2.18) 1.15 (0.81 – 1.64) 
Ethnicity 
Indigenous 
Non – indigenous 
 
0.62 
. 
 
(0.35 – 1.10) 
. 
 
0.80 
. 
 
(0.60 – 1.07) 
. 
Socioeconomic level 
1st quintile 
2nd quintile 
3rd quintile 
4th quintile  
5th quintile 
 
0.56 
0.77 
0.83 
0.79 
. 
 
(0.27 - 1.20) 
(0.39 – 1.50) 
(0.40 – 1.75) 
(0.44 – 1.42) 
. 
 
0.63 
0.78 
0.84 
1.00 
. 
 
(0.39 – 1.01) 
(0.48 – 1.27) 
(0.53 – 1.33) 
(0.63 – 1.58) 
. 
Employment 
Unemployed 
Retiree  
Housekeeper 
Employed 
 
1.72 
1.53 
1.20 
.  
 
(0.72 – 4.13) 
(0.73 - 3.20) 
(0.68 – 2.10) 
. 
 
1.06 
1.44 
1.09 
. 
 
(0.65 – 1.73) 
(0.87 – 2.38) 
(0.75 – 1.57) 
. 
Health insurance 
None 
Seguro Popular 
Else*  
 
0.47 
0.73 
. 
 
(0.18 – 1.19) 
(0.39 – 1.37) 
. 
 
0.44 
0.82 
. 
 
(0.30 – 0.67) 
(0.60 – 1.13) 
. 
Diabetes duration 
(per 5 years) 
1.14 (0.99 – 1.30) 1.02 (0.94 – 1.11) 
Comorbidities 
Yes  
No 
 
1.07 
. 
 
(0.61 – 1.87) 
. 
 
1.51 
. 
 
(1.15 – 1.96) 
. 
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Continuation Table 12.  
 ≥ 4 Annual physician visits 
(n = 2546) 
 OR  95% CI 
Residency 
Rural  
Urban 
 
1.20 
. 
 
(0.87 – 1.65) 
. 
Age  
≤ 40 
41 – 60 
61 – 80 
> 80 
 
. 
0.49 
0.54 
0.58 
 
. 
(0.16 – 1.44) 
(0.20 – 1.52) 
(0.20 – 1.67) 
Female gender 1.43 (0.93 – 2.20) 
Ethnicity 
Indigenous 
Non – indigenous 
 
0.89 
. 
 
(0.65 – 1.23) 
. 
Socioeconomic level 
1st quintile 
2nd quintile 
3rd quintile 
4th quintile  
5th quintile 
 
1.05 
0.91 
0.90 
1.09 
. 
 
(0.61 – 1.78) 
(0.52 – 1.60) 
(0.53 – 1.54) 
(0.63 – 1.89) 
. 
Employment 
Unemployed 
Retiree  
Housekeeper 
Employed 
 
1.27 
1.25 
1.45 
. 
 
(0.70 – 2.30) 
(0.73 – 2.10) 
(0.95 – 2.22) 
. 
Health insurance 
None 
Seguro Popular 
Else  
 
0.23  
0.70 
. 
 
(0.15 – 0.36) 
(0.49 – 1.01) 
. 
Diabetes duration (per 5 years) 1.22 (1.10 – 1.34) 
Comorbidities 
Yes  
No 
 
1.14 
 
(0.85 – 1.52) 
*Else = Private or institutional health insurance (IMSS/ISSSTE, Pemex, Defensa/Marina 
1Bold numbers indicate significant test result.   
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2.6 Discussion 
2.6.1 Major Findings 
Rates for diabetes and diabetes complications were distributed unequally across 
Mexico’s 32 federal states and among rural and urban areas. Across states, the 
prevalence of diabetes ranged from 5% to 11% of whom 42% to 77% reported 
diabetes complications (Chapter 2.1.3, Figure 8). Diabetes prevalence was higher in 
urban areas, at 9%, versus 7% in rural areas. However, the distribution was inversed 
for diabetes complications: approximately 70% of residents from rural areas reported 
microvascular diabetes complications versus 60% in urban areas.  
Results suggest that diabetes outcomes are associated with social determinants, in 
particular lack of health insurance (OR = 1.62; 95%CI = 1.15 – 2.27) and lower 
educational status (less than primary school compared to secondary school or more: 
OR = 1.46; 95%CI = 1.00 – 2.15) (Table 9). However, this association was not 
consistent with other socioeconomic factors, such as a high level of marginality, which 
did not increase someone’s odds of having diabetes complications.  
Socioeconomic differences were partially reflected in the geographical disparities of 
diabetes complication rates. Areas with high complication rates were observed to 
conglomerate in the centre and along the Gulf Coast and were lowest in the northwest 
(along the US-Mexican border) and southeast (on the peninsula of Yucatán) region of 
Mexico. Those areas with high rates of self-reported diabetes complications (= HCR 
states: ≥65% of all people with diabetes complications) had higher proportions of rural 
residents (23% versus 13%, p<0.001) and more individuals receiving public health 
care (35% versus 29%), p = 0.033 (Chapter 2.5.3).  
It is noteworthy that individuals from states with high complication rates reported a 
lower frequency of diabetes care participation; 38% in states with intermediate-/low 
complication rates versus 32% in states with high complication rates received the 
recommended quarterly diabetes controls with a physician (p=0.004). 
Similarly, residents from rural areas with diabetes complications received 
recommended diabetes care to a lesser extent compared to their urban counterparts. 
For example, no preventive measures were reported from 29% of urban residents 
versus 40% from rural residents, resulting in 0.7 times lower likelihoods for reported 
reception of diabetes care (95%CI = 1.02 – 1.90) among rural residents. Surprisingly, 
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neither indigenous origin nor lack of health insurance had a significant impact on the 
self-reported reception of diabetes care screenings. 
The observed differences may provide supplementary information for the 
implementation of local prevention policies to improve diabetes care, especially in 
rural areas and socioeconomically deprived areas.  
2.6.2 Social and ethnic determinants of diabetes outcome and care 
We assumed that socioeconomic factors mediate the use of preventive measures and 
presence of diabetes complications, reflected by geographical clustering of areas that 
show high diabetes complication rates and lower socioeconomic or developmental 
profiles and infrastructural resources compared to areas with lower diabetes 
complications rates. As a prerequisite, we examined if socioeconomic status (SES) 
was associated with diabetes complications among ENSANUT survey participants 
and found that SES was significantly associated with increased self-reported presence 
of microvascular complications in the descriptive analysis. Approximately 60% of the 
people with diabetes complications belonged to the lowest three socioeconomic 
quintiles. Among people without diabetes complications in the same socioeconomic 
groups only 51% belonged to the lowest three quintiles (p<0.001) (Table 8). After 
adjustment for other variables that have been associated with the presence of diabetes 
complications in former publications (age, diabetes durations, diabetes treatment, 
presence of comorbidities and type of health insurance), the likelihoods for presence 
of diabetes complications were still about 1.3 to 1.5 times higher for households with 
lower socioeconomic status (Table 9). 
These findings, which were extracted from a national representative survey, support 
the argument that the presence and development of diabetes complications are 
associated with the socioeconomic situation of Mexican individuals with diabetes. 
Despite numerous economic improvements in recent years, including the introduction 
of public health care for formerly uninsured people, the use of preventive diabetes 
care may still be limited by area of residency and the associated socioeconomic 
differences among Mexico’s regions. According to our results, residents from lower 
socioeconomic households encountered more barriers to diabetes care consultations. 
For example, those with a reported lack of diabetes care interventions had lower 
school degrees, received more often funding from public health care or had no health 
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care insurance and a higher proportion lived in rural areas. Residency in rural areas 
provided consistent results and was associated with more diabetes complications and 
inconsistent utilisation of preventive diabetes care.  
 
These results were conform with previous findings, in which lower education, low or 
middle income, receipt of public assistance and irregular employment were positively 
associated with the presence of nephropathy or retinopathy(Funakoshi et al., 2017). 
Additionally, Delmerico (2013) reported that social determinants, e.g., educational 
achievement and higher poverty rates, were major factors that led to hospitalisations 
for diabetes-related complications(Delmerico, 2013). 
Another study from the UK found that OR increased for sight-threatening DR and 
decreased by 11% for ophthalmologic screenings with each increasing quintile of 
deprivation(Scanlon et al., 2008). However, results for the association between 
socioeconomic status and utilisation of preventive measures seemed to be less 
consistent. One study conducted in Canada found that referral rates to a diabetes 
centre did not differ across all income quintiles(Rabi et al., 2006).  
In this analysis, we found high associations between socioeconomic status and receipt 
of ophthalmologic exams across people with diabetes complications. However, these 
results missed the 95% significance threshold, except for the third quintile when 
compared to people from the highest socioeconomic quintile (5th quintile), (OR (3rd-
quintile)=0.35; 95%CI = 0.16-0.78)). Likewise, HbA1c determination was less 
common among people from the lowest socioeconomic quintile compared to those in 
the highest quintile (OR= 0.40; 95%CI = 0.21 – 0.76) (Table 12). Other screenings or 
physician visits did not demonstrate significant associations with SES, although all 
reflected the same trend with lower OR for lower quintiles compared to the highest 
quintile.  
 
We also assumed that indigenous people were less likely to receive diabetes care due 
to multiple socioeconomic and cultural barriers and would have higher odds of 
reporting microvascular complications. However, contrary to previous reports 
concerning diabetes management and outcomes among ethnic minorities (Karter et 
al., 2002; Mainous, Diaz, Koopman, & Everett, 2007; Nwasuruba, Osuagwu, Bae, 
Singh, & Egede, 2009) Mexico’s indigenous population did not differ significantly 
from the non-indigenous population. People of indigenous origin in this study had 
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comparable likelihoods for the presentation of diabetes complications to non-
indigenous groups (OR =0.96, 95%CI = 0.73 – 1.20) (see Table 9). Similarly, 
diabetes follow-ups with screenings for end-organ damage were provided equally to 
indigenous and non-indigenous people. Analogue results from the ENSA 2000 (the 
first national health and nutrition survey in Mexico) demonstrated that health care 
utilisation was not significantly lower for indigenous groups. In contrary, Handa 
(2007) found that the indigenous population had significantly higher rates of curative 
care utilisation(Handa, 2007). This apparent protective trend among those of 
indigenous origin and those presenting diabetes complications was surprising, as 
ethnic minorities in Mexico and other countries experience higher systems-level 
barriers to receiving adequate health care(Golden et al., 2012; Spanakis & Golden, 
2014). For example household incomes of ethnic minorities in rural areas were 40% 
to 50% lower than those of rural non-indigenous households, and 44.2% of people 
residing in indigenous municipalities were suffering from extreme poverty in 2010 
(Hale et al., 2010; Leyva-Flores, Servan-Mori, Infante-Xibille, Pelcastre-Villafuerte, 
& Gonzalez, 2014). Non-indigenous groups in Mexico were also more likely to have 
received medical care due to a problem that occurred in the previous two weeks 
compared to indigenous groups (58% versus 53%, respectively). Lack of receipt of 
medical assistance was mainly attributed to a lack of money or lack of service supply 
(lack of confidence, ill-treatment, unavailability and remoteness). However, 
significant differences disappeared after adjustment for socioeconomic factors among 
indigenous and non-indigenous groups. Thus, the authors concluded that 
socioeconomic conditions and the type of health care provider rather than ethnic 
differences determined people’s utilisation of primary health care(Leyva-Flores et al., 
2014). Similar reports support the conclusion that socioeconomic determinants have 
stronger effects on diabetes outcomes than ethnicity itself (Link & McKinlay, 2009; 
Osborn, de Groot, & Wagner, 2013). For example, one study found that lack of 
seeking health care among indigenous groups was related to linguistic, geographic, 
economic and cultural aspects(Ibáñez-Cuevas, Heredia-Pi, Meneses-Navarro, 
Pelcastre-Villafuerte, & González-Block, 2015). In this context, it is conceivable that 
intra-ethnic effects are levelled out when we compare all indigenous groups to non-
indigenous groups. For example in the ENSANUT 2012, 23.0% (N=158) of people 
living in Chiapas did not speak Spanish compared to 6.7% (N=58) in Yucatán. 
Additionally, the southern region is geographically divided by three major mountain 
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ranges (Sierra Madre del Sur, Sierra Madre de Oaxaca and Sierra Madre de Chiapas) 
that disperse and isolate indigenous communities in this region, leading to the lower 
accessibility of health care. However this situation may be different for indigenous 
communities in the northern area and access to diabetes care might be similar to non-
indigenous groups. Therefore, a state- or community-level analysis of diabetes 
outcomes and health care utilisation among indigenous people could provide further 
information and validate the possible effects of intra- and inter-ethnic differences 
(Bello-Chavolla, Rojas-Martinez, Aguilar-Salinas, & Hernandez-Avila, 2017).  
2.6.3 Effective access to diabetes care  
Previous reports have clearly demonstrated that the implementation of public health 
care and other specific programs targeting the poorer population were successful in 
improving health care access in general and diabetes care in particular  
(Consejo Nacional de Evaluación de la Politíca de Desarollo Social (CONEVAL), 
2014; Sosa-Rubí et al., 2009; Tapia-Conyer et al., 2013; Thoumi, Udayakumar, 
Drobnick, Taylor, & McClellan, 2015). People enrolled in public health care (‘Seguro 
Popular’) compared to the uninsured population received on average 3.13 more 
insulin injections per week, had lower proportions of poor blood glucose control 
(37.6% versus 46.2%) and had greater access to blood glucose tests (Sosa-Rubí et al., 
2009). Flores-Hernandez et al. (2015) demonstrated improvements with regard to 
diabetes care over a six-year period in Mexico, comparing data from ENSANUT 
2006 and 2012. There were relative improvements with regard to Urine MiA-, HbA1c 
testing and foot revision of 6.4%, 4.2% and 5.8%, respectively. The author concluded 
that many of the improvements were due to increasing public health care 
affiliations(Flores-Hernandez et al., 2015).  
However, some areas of Mexico seemed to have difficulties providing effective 
access to health care. According to our results, 16% of the diabetic population did not 
have any health insurance, 31% received public health care (‘Seguro popular’) and 
53% were affiliated with social security (IMSS, ISSSTE, Pemex, etc.). The 
population without health insurance represented the group with the greatest 
vulnerability to poor diabetes outcomes among all health care types. The likelihood of 
this group presenting diabetes complications was 1.62 times higher compared to 
people receiving tax-funded social security (IMSS, ISSSTE, and other, Social 
Security services) (OR = 1.62; 95%CI = 1.15 – 2.27) even after adjustment for other 
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socioeconomic factors. Although this did not reach the significance threshold, we 
considered it noteworthy that SP affiliates had higher odds of presenting diabetes 
complications (OR =1.10, 95%CI = 0.83-1.46) and had lower odds for regular 
diabetes follow-ups with their physicians (OR = 0.70, 95%CI: 0.49-1.01) compared to 
people receiving tax-funded social security (see Table 9). In accordance with these 
findings, another document confirmed that close to 35% of the population with SP 
affiliation in 2010 did not receive medical attention despite having a health problem 
because it was ‘too expensive’, they ‘had to wait too long’ or they ‘did not receive 
treatment’(Consejo Nacional de Evaluación de la Politíca de Desarollo Social 
(CONEVAL), 2014). This is problematic in terms of treatment adherence of chronic 
conditions. A report from CONEVAL explains the underutilisation of health services 
among public health care users by a relative decrease in health care providers 
compared to the fast increase of health demands in the population, which led to long 
waiting hours and shortfalls in equipment and quality of care(Consejo Nacional de 
Evaluación de la Politíca de Desarollo Social (CONEVAL), 2014). In patients with 
chronic conditions, treatment adherence depends on regular follow-ups and diabetes 
controls. However, the quest for universal health care in Mexico needs further 
improvements to facilitate the utilisation of these preventive measures and increase 
efforts to provide effective access to diabetes care.  
 
2.6.4 Diabetes care in rural areas  
Previous research has demonstrated that barriers to receive health care were 
substantially higher in rural areas compared to urban areas(Brems, Johnson, Warner, 
& Roberts, 2006). Residents from small communities with only one health care centre 
frequently experienced lack of access to medications, poor health care quality and a 
small timeframe for possible consultations. For example, rural primary health care 
centres had difficulties providing drugs, resulting in only 56% of patients receiving 
the prescribed medicine(Tapia-Conyer et al., 2013). Accordingly, results of self-
reported data from the ENSANUT 2012 indicate that the majority of Mexicans with 
diabetes complications did not receive ADA-recommended standards of diabetes 
care, with greater effects for rural communities. In the descriptive analysis, obtaining 
specific screenings for the detection and prevention of diabetes complications 
(HbA1c tests, ophthalmologic exams, foot/leg and urine screenings) were 
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significantly less common among rural residents (rural vs urban: eye revision: 5.6% 
vs. 10.5%, p=0.006; foot revision: 10.8% vs. 17.9%, p=0.002; urine screening: 
6.2.0% vs. 10.6%, p=0.074; Hba1c monitoring: 6.5% vs. 10.5%, p=0.037, Table 11). 
A minority in both groups received comprehensive care with all three and all four 
preventive measurements that were performed in the past year (0.9%, n=24 and 0.3%, 
n=3, respectively). Yet the frequency of doctor visits did not differ between the two 
groups in descriptive analysis (the rate of four or more annual physician visits was 
about 70% among individuals with diabetes complications in urban as well as in rural 
areas). Surprisingly in logistic regression analysis, where we controlled for age, sex, 
socioeconomic differences and ethnic differences, individuals from rural areas had 
higher odds to receive four or more diabetes controls per year, however the 
confidence interval was very large so that the level of uncertainty of this effect was 
considered too high to draw any conclusion from it (OR = 1.20; 95%CI = 0.87 – 1.65; 
Table 12). 
Also venous blood glucose determination was widely used in rural as well as in urban 
areas (49% and 59% of patients with diabetes in rural and urban areas respectively). 
This might result from the widely available and accepted venous blood glucose tests 
that seem to replace the application of the other specific (time- and cost intensive) 
methods such as foot-, eye-, urine- revision and HbA1c analysis.  
The rate for not receiving any specific preventive measure was high across both 
groups and even higher for rural residents; 71% of the respondents living in rural 
areas compared to 59% in urban areas (p=0.001) reported that they did not receive 
diabetes care. In conclusion, a majority of respondents with diabetes complications 
(approximately 70% in rural and urban areas) reported to see their doctor for diabetes 
controls on a regular and frequent basis (four times or more per year). However 
diabetes follow-ups that covered all screening tests were carried out only for a small 
percentage of attending patients according to patients’ self-reports.  
A previous study, conducted by Nathan et al. (2010), demonstrated higher rates for 
DR and DF among rural residents compared to urban residents in the US. 
Correspondingly, they observed that rural residents were less likely to engage in foot 
and eye revision. However, the overall frequency for diabetes care consultation, 
independent of area of residency, was significantly higher in the US. For example, 
foot and eye exams were carried out in more than 70% of all cases, while this was 
true in 5% to 18% of cases in Mexico(Hale et al., 2010).   
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2.6.5 Regional disparities in diabetes outcome 
High diabetes complications were primarily clustered in the centre, from the Pacific 
region to the Gulf Coast. Lowest complication rates were observed in the northwest, 
in three states bordering the state of Mexico and on the peninsula of Yucatán (Figure 
8). Diabetes complication prevalence largely differed between the states, ranging from 
42% to 77% (Figure 9). In descriptive analysis, distinguishing characteristics of 
people living in states with high diabetes complication rates were affiliation with 
public health care or lack of health insurance, rural residency and lower proportions of 
people receiving preventive diabetes care. An interesting observation was that some 
states substantially differed regarding the prevalence of diabetes and diabetes 
complications. We observed that three states (Chiapas, Michoacán (southern Mexico) 
and Guanajuato (central Mexico)) had very low rates of diabetes in the general 
population and very high rates of diabetes complications among people with diabetes. 
It is plausible that individuals from these states remained undiagnosed until symptoms 
of diabetes-related complications occurred. Thus, the inverse patterns of ‘below-
average diabetes prevalence’ and ‘above-average-complication rate’ could be used as 
a surrogate parameter to indicate late diabetes detection and higher measures of 
people with undiagnosed diabetes. However this remains a theory and needs to be 
evaluated. 
We also compared the visual distribution of rural residency, health insurance status 
and health care utilisation among people with diabetes with the distribution of 
diabetes complication across Mexican states in order to determine states with the 
greatest need for improvement of access to diabetes care.   
Since previous results suggested that rural residency, diabetes care utilisation, 
socioeconomic status and partially health care status impact diabetes outcomes, we 
considered three possible barriers to effective accessibility of diabetes care:  
1. Residency in areas with low developmental profiles and large rural areas  
2. Lack of health insurance or large proportions of public health care affiliates  
3. Low diabetes care participation. 
With our results we raise the hypothesis that the south and partially the central 
regions met the greatest challenges to providing adequate diabetes care and 
improving diabetes outcome. First, because people from the south were more likely to 
be covered by public health care or did not have any health insurance (see Figure 12). 
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As outlined before, a report by CONEVAL found that effective access to public 
health care decreased in recent years due to the large increase of public health care 
affiliates, and a serious relative decrease of hospital beds per 1,000 public health care-
affiliates was noted in a two-year span (from 2008 to 2010), especially in the southern 
and central states bordering the south of Mexico(Consejo Nacional de Evaluación de 
la Politíca de Desarollo Social (CONEVAL), 2012). Second, we found that the 
proportion of those living in rural areas among people with diabetes was larger in the 
south compared to the north (17% - 41% in the south versus 4.9% - 18% along the 
border US-Mexican border) (Figure 14).  
 Third, the developmental profile of southern states (using the HDI Index as surrogate 
parameter for development) was lower (see Figure 11), similar to previous findings 
about the socioeconomic south-north divide of Mexico and the increased diabetes 
burden of southern states(Barquera, Tovar-Guzmán, Campos-Nonato, González-
Villalpando, & Rivera-Dommarco, 2003; Stevens et al., 2008; Villalpando et al., 
2010). However, this hypothesis relies on the visual inspection of choropleth maps 
and we suggest that this theory needs further verification using multilevel logistic 
regression analysis, as described and applied in other countries for similar 
purposes(Khan & Shaw, 2011; Zhou et al., 2015). 
 
2.6.6 Limitations 
We visually compared the distribution of diabetes complications across Mexican 
states with the distribution of people with diabetes living in rural areas. Despite 
significant associations among rural residency and diabetes complications in former 
analysis, we could not find a visual association. The same situation was observed for 
affiliation to public health car or absence of any health insurance.  
A possible explanation is that the explanatory power of our logistic regression models 
is overall low. It is likely that statistical significance cannot be observed visually 
because associations were rather small. Also other factors that were not included in 
the analysis may have had larger impacts on the presence of diabetes complications. 
One of those unmeasured variables could be the different expansion pattern of public 
health care across Mexico’s states. Access to public health care did not unfold equally 
across the country, and areas with lower socioeconomic profiles and poor 
infrastructure lagged behind in achieving effective health care coverage by public 
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health care (Seguro Popular)(Beltran-Sanchez, Drumond-Andrade, & Riosmena, 
2015). As a result, areas where effective access to health care enabled formerly 
uninsured people to seek medical care might have better diabetes outcomes than areas 
that lagged behind in the integration process of Seguro Popular. However, this effect 
on diabetes outcomes remains unknown, as we did not include the year of affiliation 
with Seguro Popular in this analysis. 
Undetected diabetes is one of the most important limitations of this study and is 
known to be a major problem in population-based surveys. In the Mexican Health and 
Aging study, undiagnosed diabetes in Mexico among people older 50 years was about 
18%(Kumar, Wong, Ottenbacher, & Al Snih, 2016). The IDF reported undiagnosed 
diabetes rates in North America and the Caribbean of 25% to 29.4% among people 
aged 20 to 79 years old in 2012. In the ENSANUT 2006, a diabetes prevalence of 
7.1% was reported with an expected overall prevalence of around 14%(Sosa-Rubí et 
al., 2009), and only 23.7% of the adult population was screened for T2DM(Gutierrez 
et al., 2012). However, we could not find state-level information on the rates of 
undiagnosed diabetes.  
Biases in population data  
It was noteworthy that the excluded survey participants were significantly older 
(Mean(excluded) = 71 years versus Mean(included) = 56 years, p<0.001)) and had a 
significantly longer diabetes duration ((Mean (excluded) = 16 years versus 
Mean(included) = 9 years, p<0.001; Table 7)). Although not significantly different, 
excluded participants were also more likely to be of indigenous origin, lived in rural 
areas and had lower socioeconomic backgrounds. This raises the hypothesis that the 
target population of this analysis (the rural, remote and poor population) are not 
represented very well and that very comorbid and old patients with diabetes 
complications are not included because they are not able to participate in surveys, 
resulting in a selection bias. In general undiagnosed diabetes in self-reported data 
needs to be taken into consideration when interpreting results. Just alike old and 
comorbid survey participants, those with poor access to health care due to financial 
incapacities or infrastructural reasons, such as residency in remote areas, might 
remain undetected despite the presence of diabetes complications. In another 
publication, people living in rural areas had the lowest detection rates of 
diabetes(Zhou et al., 2015). This in turn suggests that no differences exist in diabetes 
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outcomes and care among minorities or underserved populations in comparison to the 
general population. This effect could explain why there was no difference between 
indigenous and non-indigenous populations, neither in diabetes care utilisation nor in 
diabetes outcome because those with poor outcomes due to marginality were not 
included to this analysis. 
Further limitations could have resulted from survival bias in remote areas and 
unfavourable living conditions. In other words, these people have a higher chance of 
dying from diabetes complications before diabetes is detected, similar to previous 
findings from India, which demonstrated that urban areas had higher rates of diabetes 
complications. This was explained by the ‘selective mortality’ of people with diabetes 
living in rural areas(Lee et al., 2015). However, this question is left to speculation, 
and we suggest that further research on diabetes, its outcome and health care 
utilisation needs to be carried out, as mentioned before.  
We further recognise that we did not countercheck the plausibility of responses. In 
this regard, recall bias, resulting from people’s capabilities of providing precise health 
status reports, might be present. This depends on several factors like age, morbidity 
and individual health perceptions. For example, old and multi-morbid people may 
find it difficult to recall a diagnosis of a doctor. However, we tried to evaluate the 
concordance of self-reported data and clinical trials with the systematic literature 
review, and we suggest that all presented results need to be read with care in terms of 
making generalisations. Also desirability bias can often be observed in population 
data, since survey participants might be aware that preventive diabetes care is 
necessary and recommended by the doctor. Therefore the proportion of people with 
four or more diabetes consultation might be higher than it actually is because people 
know they should have seen the doctor at least four times per year. On the other hand, 
some people may not know what a preventive measure is or cannot name the 
preventive exam, which lead to the erroneous assumption that more people did not 
receive the recommended preventive diabetes exam. 
Not all factors that theoretically contribute to poor treatment adherence, as described 
in the introduction, and that were identified in other publications were available for 
data analysis. Therefore, it is likely that residual confounding due to unmeasured 
characteristics exist. For example, our models did not account for geographical 
differences caused by transportation issues and distance to primary health care 
centres/clinics as well as for the physician density between states and areas, since 
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these variables were not measured in ENSANUT 2012 data. In a previous study 
conducted in Mexico in 1998, lower utilisation rates for preventive measures were 
partially explained by infrastructural issues, in particular the distance to the main road 
and to health clinics(Handa, 2007). Identification of areas where the infrastructure 
limits treatment adherence is important for strategic health care intervention. For 
example, public health care enrolees living in areas with an above-median number of 
physicians and more health units per population of 1,000 had higher odds of receiving 
blood glucose tests (OR= 15.85) and lower odds of displaying poor blood glucose 
control (OR= 0.20)(Sosa-Rubí et al., 2009). This is possibly even reflected in the low 
measures of fit for the logistic regression models in this analysis. Area of residency 
and socioeconomic and individual factors were responsible for only a small portion of 
increased diabetes-complication rates and the lack of compliance with treatment 
follow-ups. 
Furthermore, the established conceptual framework did not account for differences 
concerning genetic susceptibility and family history of diabetes complications. This 
might further limit the explanatory power of this work. However, we did not intend to 
explore all possible risk factors for diabetes complications but rather tried to evaluate 
the impact of socioeconomic and associated geographic determinants that contributed 
to the development of diabetes complications. 
With regard to the results of diabetes outcomes across Mexico’s 32 federal states, we 
were not able to perform a detailed analysis of contributors for each complication 
based on the limited numbers of cases. It is difficult to generalise results, particularly 
for low prevalent complications like diabetes kidney disease. For this reason, we only 
distinguished between the presence and absence of any of the mentioned 
complications. However, this analysis refers to selected diabetes complications, and 
the pattern or distribution of diabetes complications across states may change 
depending on investigated diabetes complications. More cases with diabetes 
complications could contribute to a more detailed picture of the development of 
complications, enabling investigations for each complication on a state or even 
community level. We suggest that state-level observations on prevalence of diabetes 
complications and socioeconomic indicators need to be further analysed using 
multilevel analysis. Multilevel logistic regression has been demonstrated as a positive 
approach to linking the socioeconomic characteristics of areas (e.g. states, 
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municipalities, neighbourhoods, etc.) with individual health(Merlo et al., 2006; Zhou 
et al., 2015).  
Furthermore, we cannot make a statement on the quality of care from a provider 
perspective. Our results suggest that patients do not receive diabetes care as 
recommended and that physicians do not provide adequate diabetes care because few 
patients recalled receiving preventive screenings in the past year. Rodriguez-Saldana 
et al. (2010) claimed that quality of diabetes care in Mexico was still deficient as a 
result of scarce resources at the primary health care level, guideline non-adherence of 
physicians and persisting acute disease approaches instead of application of a 
multidisciplinary strategy focused on the prevention of long-term 
complications(Rodríguez-Saldana et al., 2010). In high demand–low resource settings 
where physicians do not have the time and means to carry out comprehensive 
diabetes care and screenings because of high patient emergence, the quality of 
diabetes care might be particularly lower than in urban and metropolitan areas where 
physician density is higher. However, information on the quality of health in remote 
areas is scarce, and the high rate of microvascular diabetes complications in some 
areas might reflect deficiencies in diabetes care, which need to be verified and 
addressed by further research.   
2.7 Conclusion 
In summary, the results presented here demonstrate that rates of diabetes 
complications vary in Mexico depending on residency, federal state and on inter-
individual factors indicating inequalities in access to health care and differences in the 
quality of health care and prevention. We could not find a direct relationship between 
the geographical pattern of diabetes complications and socioeconomic or health care 
characteristics of states. Only some states in the south showed the tendency to be 
more affected by socioeconomic- and health care status and diabetes care 
participation in terms of diabetes outcome. Though we found that comprehensive 
diabetes care was overall low in Mexico. Individuals living in rural and lower 
socioeconomic settings had higher likelihoods of presenting diabetes complications 
and were less likely to receive diabetes care. Assuming that the southern region is still 
undergoing transformation, as suggested by Stevens et al. (2008), life expectancy will 
further increase with augmenting proportions of older people, resulting in a greater 
incidence and prevalence of DM (Stevens et al., 2008). Diabetes complications are 
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associated with increasing age and diabetes duration. Therefore, we expect that states 
at pre-transitional stages will experience larger economic impacts caused by DM and 
that they will have less time to react to the consequences of DM compared to states 
that have higher developmental profiles(Corriere, Rooparinesingh, & Kalyani, 2013). 
States with high diabetes complication rates need to improve treatment adherence and 
intensify current programs that support the utilisation of preventive measures and 
screenings. Furthermore, states at earlier transitional stages and with high diabetes 
complication rates require more financial support by the government. Allocation of 
financial resources from higher developed to lower developed states could support the 
implementation of preventive programs.  
An approach that has shown promising effects on diabetes outcome is the 
implementation of community health workers (CHWs). A growing body of evidence 
suggests that knowledge about diabetes, self-monitoring and self-care as well as 
lifestyle changes improve with the intervention of CHWs(Shah, Kaselitz, & Heisler, 
2013). Another document found that even CHWs without formal professional 
medical training were successful in providing screenings and identifying high-risk 
patients(Gaziano et al., 2015). These types of CHW programs could gain more 
importance in the future, especially in low-resource settings, in order to effectively 
provide diabetes care and screening at low costs. In rural Chiapas, a non-
governmental organisation introduced a CHW program with visits at three-month 
intervals in addition to routine physician visits. First results demonstrated that blood 
pressure levels were significantly lower for those that reported treatment adherence. 
However, further evidence on the cost effectiveness and feasibility of CHW programs 
is needed(Newman et al., 2015). 
Multifaceted approaches that intervene at different levels are necessary; e.g. on health 
care provider level to improve the implementation of diabetes care, on patient level to 
improve understanding and compliance for preventive measures and from health 
policy makers in order to decrease barriers for diabetes care by assuring that costs for 
diabetes care are covered. Otherwise the rising prevalence of diabetes and associated 
complications have the potential to enlarge the gap between the rich and the poor 
population and decelerate developmental changes. 
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Appendix 
 
 
Description of Variables  
 
Presence of diabetes complications was defined as reporting at least one previous 
diagnosis of diabetic foot or leg ulcer, amputation, visual impairment, diabetic 
retinopathy, blindness, diabetic neuropathy and/or diabetic nephropathy requiring 
dialysis. This variable was composed using the following command: A313a-h 
represent the variables defining each complication that were included into our 
analysis. describes all variables that were used for univariate and multiple logistic 
regression analysis.  
 
COMPUTE kom_ges = 0. 
IF a313a = 1 kom_ges = 1. 
IF a313b = 1 kom_ges = 1. 
IF a313d = 1 kom_ges = 1. 
IF a313e = 1 kom_ges = 1. 
IF a313h = 1 kom_ges = 1. 
EXECUTE. 
 
Table 13. Variables used for univariate and multiple logistic regression analysis 
Variable name Description Measure Values 
SOCIODEMOGRAPHIC VARIABLES /RESIDENCY  
Edad Age in years Scale 20 – 114 years 
Age_binned Age in years Categorical 1 = ≤ 40years 
2 = 41-60 years 
3 = 61-80 years 
4 = > 80 years 
Sexo Gender Nominal 0 = Male 
1 = Female 
Entidad Federal states String 01 = Aguascalientes 
02 = Baja California North 
03 = Baja California South 
 115 
04 = Campeche 
05 = Coahuila 
06 = Colima 
07 = Chiapas 
08 = Chihuahua 
09 = Federal district 
10 = Durango 
11 = Guanajuato 
12 = Guerrero 
13 = Hidalgo 
14 = Jalisco 
15 = Mexico 
16 = Michoacán 
17 = Morelos 
18 = Nayarit 
19 = Nuevo Leon 
20 = Oaxaca 
21 = Puebla 
22 = Queretaro 
23 = Quintana Roo 
24 = San Luis Potosi 
25 = Sinaloa 
26 = Sonora  
27 = Tabasco 
28 = Tamaulipas  
29 = Tlaxcala 
30 = Veracruz 
31 = Yucatán 
32 = Zacatecas 
state_prevalence_kom_ges states with high-, 
intermediate- 
and low rates of 
diabetes 
complications 
(HCR-,ICR-, 
LCR states) 
Ordinal 1 = ≤ 55.0% (LCR) 
2 = 55.1 – 65.0% (ICR) 
3 = > 65.0% (HCR) 
of residents with 
complications of all people 
with diabetes  
stategroups_HCRvsILCR states with high Nominal 1= HCR states 
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(state_prevalence_ 
kom_ges recoded) 
complication 
rates versus all 
other 
2 = ICR/LCR states 
Rural_residency  
(est_urb recoded) 
Area of 
residency 
 
Nominal  0 = Urban 
1 = Rural 
h215 Indigenous 
origin 
Nominal  0 = Non- indigenous  
1 = Indigenous  
quintiles Socioeconomic 
household level 
in quintiles 
Ordinal 1 = 1st quintile 
2 = 2nd quintile 
3 = 3rd quintile 
4 = 4th quintile 
5 = 5th quintile 
education  
(H218a recoded) 
Education, 
highest achieved 
school degree 
Ordinal 0 = None, Preparatory 
school, Kindergarden 
1 = less than Secondary 
2 = Secondary or more 
employment (H221 
recoded) 
Employment Nominal 0 = unemployed 
1 = employed 
2 = Retiree 
3 = housekeeper 
4 = other  
health_insurance1 
(afilia_1era recoded) 
Health care 
provider 
Nominal 0 = None 
1 = Seguro popular (public) 
2 = Other 
(Institutional/private) 
health insurance2 
(health_insurance1 
recoded) 
Health care 
provider 
Nominal  0 = None or Seguro 
Popular 
1 = Other  
DIABETES-RELATED VARIABLES 
A301  Previous 
diagnosis of 
diabetes 
Nominal 0 = no 
1 = yes 
A313a  Diabetic foot/leg 
ulcer 
Nominal 0 = no 
1 = yes 
A313b  Limb amputation Nominal 0 = no 
 117 
as a cause of 
diabetes 
1 = yes 
A313c Visual 
impairment 
caused by 
diabetes 
Nominal 0 = no 
1 = yes 
A313d Diabetic 
Retinopathy 
Nominal 0 = no 
1 = yes 
A313e Blindness caused 
by diabetes 
Nominal 0 = no 
1 = yes 
A313f Requiring 
dialysis as a 
cause of diabetes 
Nominal 0 = no 
1 = yes 
A313i  Diabetic 
neuropathy 
Nominal 0 = no 
1 = yes 
A313a,b,c,d,e,f,i Kom_ges = 
Composite 
variable; 
presence of any 
diabetic 
complication 
Nominal 0 = no 
1 = yes 
A302b Diabetes 
duration in years 
Scale 0 – 79 years 
A307 Pharmacological 
diabetes 
treatment 
Nominal 0 = None 
1 = Insulin and/or 
antidiabetic agent 
A309a  Diet to control 
diabetes 
Nominal 0 = no  
1 = yes 
A309b  Exercise to 
control diabetes  
Nominal 0 = no  
1 = yes 
A309c, A309d, A309e Composite 
variable; other 
diabetes 
treatment with 
herbs or 
alternative 
Nominal 0 = no  
1 = yes 
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medicine 
 
DIABETES COMORBIDITIES 
A401 Previous diagnosis of 
arterial hypertension 
Nominal  0 = no 
1=yes 
A601 Previous diagnosis of 
Hypercholesteremia  
Nominal 0 = no 
1 = yes 
2 = not tested  
A502a Previous history of 
Myocardial infarction 
Nominal 0 = no 
1 = yes 
A502b Previous history of 
Angina pectoris 
Nominal 0 = no 
1 = yes 
A502c Previous history of 
coronary insufficiency  
Nominal 0 = no 
1 = yes 
Cardiovascular_ 
disease 
Composite variable of 
A502a, A502b, A502c 
Nominal 0 = no 
1 = yes 
Comorbidities Composite variable of 
A401, A601, 
cardiovascular disease 
Nominal 0 = no 
1 = yes 
DIABETES CARE 
Hba1c2 (scale) HbA1c binned  Ordinal 0 = ≤ 7% 
1 = > 7% 
A310d Venous blood glucose 
test (past 12 months) 
Nominal 0 = No 
1 = Yes 
A310e HbA1c controls (past 
12 months) 
Nominal 0 = No 
1 = Yes 
A312a Foot revision (past 12 
months) 
Nominal 0 = No 
1 = Yes 
A312c Eye revision )past 12 
months 
Nominal 0 = No 
1 = Yes 
A312d Microalbuminuria test 
(past 12 months) 
Nominal 0 = No 
1 = Yes 
A312e No preventive 
measure (past 12 
months) 
Nominal 0 = Yes 
1 = No 
a312e_rec Any preventive  1 = Yes 
 119 
measure 2 = No 
doctor_visits  
(A305 recoded) 
Number of physician 
visits to monitor 
diabetes control (past 
12 months) 
Ordinal 0 = < 4 times 
1 = ≥ 4 times 
A310d, A310e, 
A312a, A312c, 
A312d 
Comprehensive health 
care, Sum of 
preventive measures 
(PM) 
Ordinal 0 = no PM 
1 = one PM 
2 = two simultaneous PM 
3 = Three simultaneous PM 
4 = four simultaneous PM 
5 = five simultaneous PM 
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